{
  "meta": {
    "title": "Community_Medicine_Test_-_1",
    "url": "https://brainandscalpel.vercel.app/community-medicine-test-1-850a5676.html",
    "scrapedAt": "2025-11-30T12:52:59.077Z"
  },
  "questions": [
    {
      "text": "A woman brought her 14-month-old child to the PHC for routine immunization. The child was born in February 2020 at home and has not received any vaccine till now due to the lockdown. The mother is apprehensive about her child's health and wants to immunize him. Which of the following vaccines can be given to the child now?<div class='question-desc-html'><ol>\n<li>OPV</li>\n<li>Measles</li>\n<li>BCG</li>\n<li>Vitamin A</li>\n<li>Pentavalent</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 4"
        },
        {
          "id": 3,
          "text": "2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 4, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct answer is <strong>1, 2, 4.</strong></p>\n<p>In the case of an unimmunized 14-month-old child,<strong> OPV, measles, </strong>and<strong> vitamin A vaccines </strong>can be <strong>given.</strong></p>\n<p><strong>Catch-up vaccination</strong> involves the administration of vaccines in children who have <strong>not been immunized at all </strong>(left-outs) or for children who <strong>took vaccines but could not complete the course </strong>(dropouts).</p>\n<p>According to the National Immunization Schedule, <strong>BCG</strong> can only be given up to <strong>1 year</strong> of age. </p>\n<p><strong>OPV</strong> can be given<strong> till 5 years</strong> of age.</p>\n<p><strong>Measles</strong> can be given <strong>till 5 years</strong> of age.</p>\n<p><strong>DPT</strong> can be given<strong> until 7 years</strong> of age (with booster doses).</p>\n<p>Only the above-mentioned vaccines have upper age limits. </p>\n<p>For pentavalent, IPV, PCV, and rotavirus vaccines, if at least one dose is given before one year of age, then remaining doses can be administered and the schedule must be completed irrespective of the age of the child. <strong>If the first dose is not administered before one year of age</strong>, then these vaccines <strong>cannot be administered to the child under UIP.</strong></p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8280",
      "difficulty": "medium"
    },
    {
      "text": "Match the following vaccines with their adverse reactions.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>Adverse reactions</strong></td>\n</tr>\n<tr>\n<td>1. Influenza (inactivated)</td>\n<td>A. Thrombocytopenia</td>\n</tr>\n<tr>\n<td>2. Measles, Mumps, Rubella</td>\n<td>B. Brachial neuritis</td>\n</tr>\n<tr>\n<td>3. Diphtheria, Pertussis, Tetanus</td>\n<td>C. Guillain-Barre syndrome</td>\n</tr>\n<tr>\n<td>4. Tetanus toxoid</td>\n<td>D. Hypotonic, hyporesponsive episode</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-C, 2-A, 3-D, 4-B"
        },
        {
          "id": 2,
          "text": "1-D, 2-B, 3-C, 4-A"
        },
        {
          "id": 3,
          "text": "1-A, 2-D, 3-B, 4-C"
        },
        {
          "id": 4,
          "text": "1-B, 2-C, 3-A, 4-D"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The option showing<strong> 1-C, 2-A, 3-D, 4-B </strong>shows the correctly matched vaccines with their adverse reactions.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>Adverse reactions</strong></td>\n</tr>\n<tr>\n<td>1. Influenza (inactivated)</td>\n<td>C. Guillain-Barre syndrome (GBS)</td>\n</tr>\n<tr>\n<td>2. Measles, Mumps, Rubella</td>\n<td>A. Thrombocytopenia</td>\n</tr>\n<tr>\n<td>3. Diphtheria, Pertussis, Tetanus</td>\n<td>D. Hypotonic, hyporesponsive episode (HHE)</td>\n</tr>\n<tr>\n<td>4. Tetanus toxoid</td>\n<td>B. Brachial neuritis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Adverse effects following vaccination</strong> (AEFI) are defined as any untoward medical occurrence following immunization that does not necessarily have a causal relationship with the usage of the vaccine. It includes unfavorable or unintended signs, abnormal laboratory findings, symptoms, or diseases.</p>\n<p>The following table shows other vaccines and rare adverse reactions observed on their administration:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vaccine</strong></p>\n</td>\n<td>\n<p><strong>Rare Adverse Reactions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Influenza (live-attenuated)</p>\n</td>\n<td>\n<p>Wheezing (children 6-11 months of age)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>JE vaccine</p>\n</td>\n<td>\n<p>Neurologic events like  encephalitis, encephalopathy and peripheral neuropathy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Measles/MMR</p>\n</td>\n<td>\n<p>Febrile seizures</p>\n<p>Encephalopathy</p>\n<p><strong>Thrombocytopenia</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tetanus toxoid</p>\n</td>\n<td>\n<p><strong>Brachial neuritis</strong></p>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Adverse Events following Immunization</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vaccine</strong></p>\n</td>\n<td>\n<p><strong>Common, Minor Reactions</strong></p>\n</td>\n<td>\n<p><strong>Rare, Serious Reactions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>BCG</p>\n</td>\n<td>\n<p>Local pain and swelling</p>\n</td>\n<td>\n<p>Suppurative lymphadenitis</p>\n<p>BCG osteitis</p>\n<p>Disseminated BCG infection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B</p>\n</td>\n<td>\n<p>Local reaction, fever</p>\n</td>\n<td>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inactivated influenza</p>\n</td>\n<td>\n<p>Local reaction</p>\n</td>\n<td>\n<p>Guillain-Barre syndrome (GBS)</p>\n<p>Oculo-respiratory syndrome</p>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>JE vaccine</p>\n</td>\n<td>\n<p>Local reaction, low-grade fever, myalgia</p>\n</td>\n<td>\n<p>Neurologic events like encephalitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Measles/MMR</p>\n</td>\n<td>\n<p>Local reactions, fever, malaise, irritability</p>\n</td>\n<td>\n<p>Febrile seizures, arthralgia, thrombocytopenia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yellow fever</p>\n</td>\n<td>\n<p>Headache, flu like symptoms, local reactions</p>\n</td>\n<td>\n<p>Vaccine-associated viscerotropic disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oral Polio</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Vaccine associated paralytic poliomyelitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DPT</p>\n</td>\n<td>\n<p>Local reaction, fever</p>\n</td>\n<td>\n<p>Neurologic events like encephalitis, seizures, HHE (hypotonic hyporesponsive episode), anaphylaxis, persistent inconsolable screaming</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of Vaccines</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Vaccines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Live attenuated</p>\n<p>(<strong>M</strong>ost<strong>&nbsp;</strong><strong>B</strong>eautiful&nbsp;<strong>P</strong>lace&nbsp;<strong>I</strong>n&nbsp;<strong>T</strong>he <strong>W</strong>orld<strong>&nbsp;</strong>-<strong> ROME)</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>M</strong>umps</p>\n<p><strong>B</strong>CG</p>\n<p><strong>P</strong>lague</p>\n<p><strong>I</strong>nfluenza (cold-adapted)</p>\n<p><strong>T</strong>yphoid (oral)</p>\n<p>Yello<strong>W&nbsp;</strong>fever</p>\n<p><strong>R</strong>ubella and&nbsp;<strong>R</strong>otavirus</p>\n<p><strong>O</strong>ral Polio (Sabin)</p>\n<p><strong>M</strong>easles</p>\n<p>Japanese&nbsp;<strong>E</strong>ncephalitis</p>\n<p>Varicella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Killed whole organism</p>\n<p>(<strong>RIP</strong> <strong>ACE</strong>)</p>\n</td>\n<td>\n<p><strong>R</strong>abies</p>\n<p><strong>I</strong>nfluenza</p>\n<p><strong>P</strong>olio (IPV, Salk)</p>\n<p>Hep <strong>A</strong></p>\n<p><strong>C</strong>holera</p>\n<p><strong>E</strong>ncephalitis</p>\n<p>Typhoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Toxoid/Protein</p>\n</td>\n<td>\n<p>Diphtheria</p>\n<p>Tetanus</p>\n<p>Acellular Pertussis</p>\n<p>Anthrax</p>\n<p>Influenza subunit&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Polysaccharide</p>\n</td>\n<td>\n<p>Pneumococcus</p>\n<p>Meningococcus</p>\n<p>Hemophilus influenza type b (Hib)</p>\n<p>Typhoid (Vi)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Glycoconjugate</p>\n</td>\n<td>\n<p>Hib</p>\n<p>Pneumococcus</p>\n<p>MenACWY(meningococcal vaccine)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Recombinant</p>\n</td>\n<td>\n<p>Hepatitis B vaccine</p>\n<p>Lyme disease</p>\n<p>Cholera toxin B</p>\n<p>HPV&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1661",
      "difficulty": "easy"
    },
    {
      "text": "An observer notes that the maternal deaths that happened in hospital deliveries in the past year are higher than maternal deaths in home deliveries. He comes to the conclusion that homes are a safer place for delivery than hospitals. This is an example of :",
      "choices": [
        {
          "id": 1,
          "text": "Direct association"
        },
        {
          "id": 2,
          "text": "Indirect association"
        },
        {
          "id": 3,
          "text": "Spurious association"
        },
        {
          "id": 4,
          "text": "Multifactorial causation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This is an example of <strong>spurious association</strong>. This is an association that appears due to improper comparison. It may lead to a spurious association or an association when none actually existed.</p>\n<div class=\"page\" title=\"Page 103\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Here, maternal mortality is likely to have been higher in hospital deliveries compared to home deliveries because hospitals attract women at high risk for delivery because of their special equipment and expertise, whereas this is not necessarily the case with home deliveries. When confounding factors and selection biases are not accounted for, it may result in incorrect conclusions regarding the association. So the conclusion that homes are a safer place for delivery than hospitals is likely to have been <strong>spurious</strong> or <strong>artifactual.</strong></p>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 103\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Association can be broadly grouped under three headings:</p>\n<div class=\"page\" title=\"Page 103\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Spurious association</li>\n<li>Indirect association</li>\n<li>Direct (causal) association\n<ul>\n<li>One-to-one causal association</li>\n<li>Multifactorial causation</li>\n</ul>\n</li>\n</ul>\n<p>Option A: <strong>Direct (causal) association</strong>- Two variables are stated to be causally related (AB) if a change in A is followed by a change in B. When factor A is present, disease B must result. <strong>Measles</strong> is one such disease in which such a relation exists.</p>\n<p>Option B: <strong>Indirect association</strong>- The indirect association is an association between a  variable and disease due to the presence of another factor, known or unknown, that is also known as the <strong>\"confounding\" variable</strong>. For example, endemic goiter is generally found in high altitudes, showing thereby an association between altitude and endemic goiter. But, endemic goiter is not due to altitude but due to environmental deficiency of iodine. Thus, a common factor (i.e., iodine deficiency) can result in an apparent association between two variables, when no association exists. </p>\n<p>Option D: <strong>Multifactorial causation</strong> is seen in <strong>non-communicable diseases</strong> or conditions (e.g., Coronary heart disease) where the <strong>etiology</strong> is<strong> multifactorial</strong>.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8423",
      "difficulty": "medium"
    },
    {
      "text": "You are a medical officer at the PHC. During the training, the PHC nursing staff asks you about the DPT vaccination. While explaining the same, you mention that the 'open vial policy' is applicable to the DPT vaccine. What do you want to convey by this term?",
      "choices": [
        {
          "id": 1,
          "text": "Once the vial is opened, it should be discarded even if it is not used completely."
        },
        {
          "id": 2,
          "text": "Once the vial is opened, it can be reused upto 4 weeks subject to certain conditions."
        },
        {
          "id": 3,
          "text": "Once the vial is opened, It can be reused upto 48 hours subject to certain conditions."
        },
        {
          "id": 4,
          "text": "Once the vial is opened, it should be kept open until it is completely used."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Open vial policy</strong> means <strong>once </strong>the vial is<strong> opened, </strong>it can be<strong> reused </strong>for<strong> upto 4 weeks </strong>subject to certain conditions.</p>\n<p>It is not applicable for BCG, JE, and measles vaccines.</p>\n<p>It is <strong>applicable</strong> for:</p>\n<ul>\n<li>DPT</li>\n<li>TT</li>\n<li>Hepatitis B vaccine</li>\n<li>OPV</li>\n<li>Pentavalent vaccine</li>\n<li>Rotavirus vaccine</li>\n<li>Japanese encephalitis vaccine (inactivated)</li>\n</ul>\n<p>Note: <strong>Open vial policy</strong> does not apply to rotavirus vaccine with VVM on cap, it applies <strong>only</strong> to <strong>new</strong> rotavirus vaccine with <strong>VVM on label.</strong></p><hr><h3>Related Pearl: Open Vial Policy</h3><p>Open vial policy allows for reuse of partially used <strong>multidose vials</strong> of applicable vaccines under the Universal Immunization Programme in subsequent sessions up to&nbsp;<strong>4&nbsp;weeks</strong> subject to certain conditions and thereby reducing vaccine wastage.</p>\n<p>It is applicable only for <strong>DPT, TT, hepatitis B vaccine, OPV, liquid pentavalent vaccine, rotavirus vaccine(new version with the VVM on the side), and JE vaccines (inactivated). </strong>It is not applicable to <strong>BCG and measles vaccines.&nbsp;</strong></p>\n<p>Vaccine vials opened in session-site can be used in more than one session up to four weeks if <strong>expiry date has not passed, if storage and transport was appropriate, no contamination has occurred in vial septum, asepsis in withdrawing was practiced and if vaccine vial monitor has not reached discard point.</strong></p>\n<p>Open vials should <strong>not</strong> be submerged in water. All open vials should have a record of&nbsp;<strong>date and time of opening</strong>. At the end of a session, all vaccines should be returned to the cold chain point and segregated as re-usable and non-reusable. All open vials of BCG, measles must be destroyed after 48 hours or before next session, whichever is earlier.</p>\n<p>In case of any <strong>adverse events following immunization</strong>, all open vials should not be discarded until investigation is complete. All vials must be transported in zipper bags in the vaccine carrier and recorded in stock register. Ice packs used should be well sealed.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6293",
      "difficulty": "medium"
    },
    {
      "text": "Meta-analysis is mainly influenced by which of the following biases?\n",
      "choices": [
        {
          "id": 1,
          "text": " Selection bias"
        },
        {
          "id": 2,
          "text": "Publication bias"
        },
        {
          "id": 3,
          "text": "Attrition bias"
        },
        {
          "id": 4,
          "text": "Recall bias"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Meta-analysis is mainly influenced by <strong>publication bias</strong>.</p>\n<p><strong>Meta-analysis</strong> is the quantitative analysis of the results of a systematic review; its validity depends on the quality of the review and the underlying studies.</p>\n<p>Publication bias occurs when studies with significant results are more likely to be published than non-significant results, misleading about the actual studies. The extent to which meta-analysis is influenced by publication bias is often assessed using:  </p>\n<ul>\n<li><strong>Selection model</strong>: Selection models use weight functions to adjust the overall effect size estimate and are usually employed as sensitivity analyses to assess the potential impact of publication bias.  </li>\n<li><strong>Funnel plot</strong>: It displays the effect size against the sample size. Normally, variability in the results will be more for smaller studies than for larger studies. So, in a funnel plot for small studies, we get an inverted funnel with more results varying from the mean. Whereas in larger studies, results cluster around the overall mean effect due to less variability. If the small studies are producing less precise results than larger studies, their results should be symmetrically spread around the mean giving rise to an inverted funnel-shaped plot. </li>\n</ul>\n<p>If this is not the case, and the results of smaller studies are distributed asymmetrically. This indicates that some unfavorable results from the study are missing due to various biases.  </p>\n<p>Option A: <strong>Selection bias </strong>– a sampling bias, non-random allocation of subjects that do not represent the population. </p>\n<p>Option B: <strong>Attribution bias </strong>– participants lost to follow-up have a different prognosis than those who complete the study. </p>\n<p>Option C: <strong>Recall bias</strong> – an objective bias, the differential ability of cases and control to recall a certain detail. </p><hr><h3>Related Pearl: Meta-analysis in Research</h3><ul>\n<li><strong>Meta-analysis</strong> is a set of <strong>statistical techniques</strong> for combining <strong>quantitative results</strong> from multiple studies to produce a summary <strong>of empirical knowledge</strong> on a given topic.</li>\n<li>It refers to a method of systematic review.</li>\n<li>It is one of the most relevant methods in evidence-based medicine and ranks high on the evidence pyramid.</li>\n<li>Limitations\n<ul>\n<li>When testing is done before hypothesis generation, spurious results are found.</li>\n<li>Sample size may be misrepresentative.</li>\n<li>Publication bias due to suppression of some important information leading to <strong>file drawer effect</strong>.</li>\n<li>Heterogeneity of studies may force mashing together of disparate effects and lead to selection bias. This is also called <strong>apples and oranges effect.</strong></li>\n<li>Dissimilarities in control groups.</li>\n<li>Its <strong>validity</strong> is dependent on the <strong>quality of the systematic review</strong> and the original data used.</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Funnel Plots</h3><ul>\n<li>A <strong>funnel plot</strong> is basically a <strong>scatter plot of individual studies</strong> which are used in <strong>systematic reviews and meta-analysis</strong>. It plots their <strong>precisions and results</strong>.</li>\n<li>In a funnel plot, <strong>each dot represents an individual study</strong>.</li>\n<li>The <strong>y-axis</strong> is usually the <strong>standard error or another estimate of precision</strong> and the <strong>x-axis is the outcome</strong>, usually the <strong>odds ratio</strong>.</li>\n<li><strong>Higher powered studies</strong> are placed towards the <strong>top</strong> and the <strong>lower powered</strong> ones towards the <strong>bottom</strong> such that the plot resembles <strong>an inverted funnel or a pyramid</strong>.</li>\n<li>This shape is expected as different studies have different standard errors and other estimates.</li>\n<li>A symmetrical funnel plot is shown in Fig. A. in the image below.</li>\n<li>These funnel plots are used in meta-analysis to check for bias like publication bias or other reporting bias.</li>\n<li>In the case of <strong>bias being present</strong>, an <strong>asymmetrical funnel plot</strong> results, as shown in Fig. B. of the image below.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/21720e796dc64464b128ea514020d1edx1280x1746.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7356",
      "difficulty": "easy"
    },
    {
      "text": "Diseases in which clinical recovery does not coincide with bacteriological recovery give rise to which kind of carrier?",
      "choices": [
        {
          "id": 1,
          "text": "Paradoxical carrier"
        },
        {
          "id": 2,
          "text": "Incubatory carrier"
        },
        {
          "id": 3,
          "text": "Convalescent carrier"
        },
        {
          "id": 4,
          "text": "Healthy carrier"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Diseases in which clinical recovery does not coincide with bacteriological recovery give rise to<strong> the convalescent carrier</strong>.</p>\n<p>In cases of typhoid fever, dysentery (bacillary and amebic), cholera, diphtheria, and whooping cough, patients <strong>continue to shed</strong> the disease agent during the <strong>period of recovery following an illness</strong> (convalescence). They pose a serious threat to unprotected household members and those in the immediate environment.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Paradoxical carriers</strong> are carriers who acquired the pathogen from another carrier. Example: A carrier with subclinical polio infection acquired the pathogen from another household member, who is also a carrier for poliovirus.</p>\n<p>Option B: <strong>Incubatory carriers </strong>are those who shed infectious agents during the incubation period and can carriers transmit the disease before the onset of symptoms. Examples: measles, mumps, polio, pertussis, influenza, diphtheria, and hepatitis B.</p>\n<p>Option D: <strong>Healthy carriers</strong> acquire the infectious agent but do not develop any symptoms of disease and keep shedding the agent. Examples: Poliomyelitis, cholera, meningococcal meningitis, salmonellosis, and diphtheria.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7822",
      "difficulty": "medium"
    },
    {
      "text": "A study shows a relationship between Oral cancer and the consumption of alcohol, with a relative risk of 1.9 and a p-value of <0.01. The study subjects are then divided into two groups: beetle nut chewers and non-beetle nut chewers. The association between Oral cancer and the consumption of alcohol is studied again, which yields an RR value of 0.87 and P value >0.05. Which of the following is the reason behind the difference between the initial RR and P value and the stratified RR and P value?",
      "choices": [
        {
          "id": 1,
          "text": "Stratified randomization"
        },
        {
          "id": 2,
          "text": "Confounding Bias"
        },
        {
          "id": 3,
          "text": "Selection Bias"
        },
        {
          "id": 4,
          "text": "Neyman’s bias"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Confounding bias </strong>is the reason behind the difference between the initial RR and P value and the stratified RR and P value.</p>\n<p>Initial analysis (<strong>before</strong> <strong>stratification</strong>) suggests that there is an association between oral cancer and the consumption of alcohol, with a relative risk of 1.9 and a p-value &lt; 0.05 ( <strong>statistically</strong> <strong>significant</strong>). Beetle nut chewing is associated with both oral carcinoma and alcohol consumption (Generally, people who consume tobacco most likely consume alcohol as well). Hence, beetle nut chewing is a potential confounder that may explain the association observed between oral cancer and alcohol consumption. Stratified analysis by beetle nut chewing status shows that both beetle nut chewers and non-chewers have an RR &lt; 1 with p-values (&gt;0.05)(<strong>statistically</strong> <strong>insignificant</strong>). The RR of 1.9 found on initial analysis disappears, and there is no true association between oral cancer and alcohol consumption.</p>\n<p>This is an example of confounding bias. <strong>Beetle nut chewing</strong> is the <strong>confounding factor</strong>.</p>\n<p>A <strong>confounding</strong> <strong>factor</strong> is defined as one that is <strong>associated</strong> with both <strong>exposure</strong> and <strong>outcome</strong> and is distributed unequally in study and control groups. In this study to determine the role of beer in the etiology of oral cancer, beetle nut chewing is considered a confounding factor because:</p>\n<ul>\n<li>It is associated with the consumption of alcohol (<strong>exposure</strong>).</li>\n<li>It is an independent risk factor for oral cancer (<strong>outcome</strong>).</li>\n</ul>\n<p>Methods to reduce confounding:</p>\n<ul>\n<li>At the <strong>time of designing</strong> the study:  </li>\n</ul>\n<ul>\n<li>\n<ul>\n<li>Randomization</li>\n<li>Matching</li>\n<li>Restriction</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>At the <strong>time of analysis</strong>:</li>\n</ul>\n<ul>\n<li>\n<ul>\n<li>Stratification</li>\n<li>Statistical modelling like regression analysis, multivariate analysis and the Cochran-Mantel-Haenszel method.</li>\n</ul>\n</li>\n</ul><p>Other options:</p>\n<p>Option A: <strong>Stratified randomization</strong>, which is also known as pre-stratification or blocking, is a technique to eliminate confounding bias. It is a process that combines both randomization and matching techniques. In this method, the participants are first grouped into subgroups that internally match with potential confounding factors such as age, race, gender, etc. An equal number of participants from each subgroup are then allocated to the study and control groups.</p>\n<p>Option C: <strong>Selection bias </strong>is a type of sampling bias that occurs because of the nonrandom allocation of subjects such that the study population is not representative of the target population. The best way to reduce this is by randomization to create groups with similar distributions of known and unknown variables. </p>\n<p>Option D: <strong>Neyman’s </strong>or<strong> prevalence-incidence bias</strong> occurs in case-control studies when exposure affects both the disease and the disease-induced mortality.</p><hr><h3>Related Pearl: Bias in Epidemiological Studies</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of Bias</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>Methods to reduce it</strong></td>\n</tr>\n<tr>\n<td>Observer bias</td>\n<td>Differential ability to observe. A <strong>subjective</strong> bias.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Interviewer's bias</td>\n<td>Interviewer asking <strong>leading questions</strong> to the subjects. Or interviewing cases thoroughly than the controls.</td>\n<td>&nbsp;Double blinding</td>\n</tr>\n<tr>\n<td>Memory/ <strong>Recall</strong> bias</td>\n<td>Differential ability of cases and controls <strong>to recall</strong> a certain detail. An <strong>objective</strong> bias.</td>\n<td>Decrease time from exposure to follow-up</td>\n</tr>\n<tr>\n<td>Surveillance bias</td>\n<td>Active surveillance leads to an <strong>increased chance</strong> of <strong>identifying</strong> the event.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Reporting/ notification bias</td>\n<td>Diseases associated with <strong>stigma</strong> are <strong>reported less.</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Berkesonian</strong> bias</td>\n<td><strong>Hospital-based case-control studies.</strong> Occurs due to differential hospital admission rates.</td>\n<td>\n<p>Randomization or Matching&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Selection bias</td>\n<td>A <strong>sampling bias.</strong> Non-random allocation of subjects that do not represent the population</td>\n<td>Randomization or Matching</td>\n</tr>\n<tr>\n<td><strong>Hawthorne</strong> bias</td>\n<td><strong>Change</strong> in <strong>attitude/</strong> actions of the subjects under <strong>observation</strong></td>\n<td>Use placebo group</td>\n</tr>\n<tr>\n<td><strong>Confounding</strong> bias</td>\n<td><strong>Factors related</strong> to <strong>both exposure</strong> and <strong>outcome</strong> distort the effect of exposure on outcome</td>\n<td>Matching, cross-over studies, randomization, or stratification</td>\n</tr>\n<tr>\n<td>Attrition bias</td>\n<td>Participants <strong>lost to follow-up</strong> have a different prognosis than those who complete the study.</td>\n<td>Randomization</td>\n</tr>\n<tr>\n<td>Pygmalion bias</td>\n<td><strong>Researcher's</strong> high <strong>expectations</strong> in the efficacy of the treatment <strong>change</strong> the <strong>outcome</strong> of that treatment.</td>\n<td>Blinding</td>\n</tr>\n<tr>\n<td><strong>Neyman's/</strong> Prevalence-Incidence bias&nbsp;</td>\n<td>Occurs due to the <strong>selective survival</strong> in <strong>prevalent cases</strong> usually seen in <strong>fatal diseases.</strong> Very sick patients are automatically excluded because of their early death.</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Neyman&rsquo;s</strong> bias or prevalence-incidence bias example: a case-control study is carried out to study the relationship between tobacco smoking and acute myocardial infarction (AMI). The cases are interviewed one week after the coronary attack. If smoker patients with AMI die more frequently, the living cases will show a lower frequency of smoking, undervaluing the association between smoking and AMI. It has been shown that the bias occurs only if the risk factor influences mortality from the disease being studied.</p>\n<p><strong>Ecological fallacy</strong> results when characteristics of the group are assigned inappropriately to individuals.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7345",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following are methods of indirect transmission of communicable diseases?<div class='question-desc-html'><ol>\n<li>Contact with soil</li>\n<li>Droplet nuclei</li>\n<li>Fomite borne</li>\n<li>Unclean hands and fingers</li>\n<li>Transplacental</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,3,4"
        },
        {
          "id": 2,
          "text": "3,4"
        },
        {
          "id": 3,
          "text": "2,3,4"
        },
        {
          "id": 4,
          "text": "3,5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"ui_qtext_para\">Among the given options, <strong>droplet nuclei, fomite borne </strong>and<strong> transmission </strong>through<strong> unclean hands </strong>and<strong> fingers</strong> are modes of<strong> indirect</strong> transmission of diseases.</p>\n<p class=\"ui_qtext_para\">Communicable diseases are classified based on the mode of transmission:</p>\n<ul>\n<li class=\"ui_qtext_para\">Direct:\n<ul>\n<li class=\"ui_qtext_para\">Direct contact (Eg: sexual intercourse)</li>\n<li><strong>Contact </strong>with<strong> soil</strong></li>\n<li class=\"ui_qtext_para\">Droplet infection</li>\n<li class=\"ui_qtext_para\">Skin or mucosal inoculation</li>\n<li class=\"ui_qtext_para\"><strong>Transplacental</strong> </li>\n</ul>\n</li>\n<li class=\"ui_qtext_para\">Indirect: \n<ul>\n<li class=\"ui_qtext_para\">Vehicle-borne</li>\n<li class=\"ui_qtext_para\">Vector-borne</li>\n<li class=\"ui_qtext_para\">Air-borne<br />\n<ul>\n<li class=\"ui_qtext_para\"><strong>Droplet nuclei</strong></li>\n<li class=\"ui_qtext_para\">Dust</li>\n</ul>\n</li>\n<li class=\"ui_qtext_para\"><strong>Fomite-borne</strong></li>\n<li class=\"ui_qtext_para\"><strong>Unclean hands </strong>and<strong> fingers</strong></li>\n</ul>\n</li>\n</ul>\n<p>The traditional 5 F's - flies, fingers, fomites, food, and fluids can be used to remember the modes of indirect transmission. Some infectious agents are able to survive in the <strong>external environment</strong> while maintaining their basic properties of <strong>virulence</strong>. This is a  requirement for this indirect transmission. </p>\n<p>An important distinction has to be drawn between droplet nuclei infection and droplet infection. The main difference between airborne droplet nuclei and droplet transmission is in the size of infected/contagious particles and whether proximity is required for transmission.</p>\n<p class=\"ui_qtext_para\"><strong>Droplet nuclei/residue</strong><strong> </strong>from<strong> evaporated droplets</strong> containing infective microorganisms can result in airborne transmission. The size of these droplet nuclei is <strong>&lt;5 μm</strong> in diameter, and they can remain suspended in the air for significant periods of time, allowing them to be <strong>transmitted over distances</strong> &gt;1 m.  There's no need for close proximity or contact. Diseases like chickenpox, measles, <strong>tuberculosis</strong>, and influenza can spread through airborne transmission.</p>\n<p class=\"ui_qtext_para\"><strong>Droplet transmission</strong> occurs when one coughs or sneezes, and contagious droplets from the infected person travel shortly in the air and directly comes in contact with another person's conjunctiva, mouth, or nasal mucosa. The particle size here is <strong>&gt;5 μm </strong>in diameter. Transmission here requires<strong> close proximity</strong> and<strong> direct contact</strong>. Examples of diseases spread via this route include the <strong>common cold</strong>, diphtheria, and whooping cough.</p><hr><h3>Related Pearl: Modes of Transmission of Communicable Diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Direct</strong></p>\n</td>\n<td>\n<p><strong>Indirect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Direct contact</p>\n<p>Droplet infection</p>\n<p>Contact with soil</p>\n<p>Inoculation into skin or mucosa</p>\n<p>Vertical (transplacental)</p>\n</td>\n<td>\n<p>Vehicle-borne</p>\n<p>Vector borne &ndash; mechanical or biological</p>\n<p>Air borne &ndash; droplet nuclei or dust</p>\n<p>Fomite borne</p>\n<p>Unclean hands and finger</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1648",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a category-II dog bite presents to the trauma center on 2nd June 2023. After the local wound management, the patient has been prescribed a schedule for rabies vaccine administration. He marks the days in a calendar as shown below when he is supposed to take the vaccine.  Which regimen is likely prescribed to the patient? What is the route of administration in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Essen regimen, intradermal"
        },
        {
          "id": 2,
          "text": "Essen regimen, intramuscular"
        },
        {
          "id": 3,
          "text": "Updated Thai Red Cross regimen, intramuscular"
        },
        {
          "id": 4,
          "text": "Updated Thai Red Cross regimen, intradermal"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The regimen prescribed here is the <strong>Updated Thai red cross regimen</strong><strong> </strong>which is <strong>intradermal</strong>.</p>\n<p>The National Rabies Control Program recommends the use of the <strong>intradermal route</strong> for administering the rabies vaccine.</p>\n<p>The<strong> Updated Thai Red Cross regimen (Intra-dermal)</strong> involves injecting <strong>0.1 ml</strong> of reconstituted vaccine per ID site and on <strong>two sites</strong> on <strong>days 0, 3, 7, and 28. </strong>(2-2-2-0-2). The first dose is given on day 0. It's important to note that the intradermal route is <strong>not recommended</strong> for individuals with <strong>compromised immune systems</strong>.</p>\n<p>On the other hand, the <strong>Essen regimen (Intra-muscular)</strong> involves injecting either <strong>1 ml or 0.5 ml</strong> of vaccine into the <strong>deltoid muscle</strong>. It consists of a <strong>5-dose regimen</strong>, with one dose given on days <strong>0, 3, 7, 14, and 28</strong>. (1,1,1,1,1)</p>\n<p>The following<strong> measures</strong> should be<strong> taken immediately </strong>to <strong>stop </strong>the<strong> contraction</strong> of <strong>rabies</strong>:</p>\n<ul>\n<li><strong>Cleansing</strong> - The most important step in the prevention of rabies is <strong>washing</strong> the affected area with <strong>plenty </strong>of <strong>soap </strong>and<strong> water </strong>under a running tap for <strong>15 minutes</strong>. This is a standard procedure that minimizes the contraction of rabies.</li>\n<li><strong>Chemical treatment</strong> - Irrigation of the wound should then be done with virucidal agents like<strong> alcohol, tincture</strong>, 0.01% solution of aqueous iodine, or <strong>povidone-iodine</strong>. Even irrigating the wound with <strong>cetrimide + chlorhexidine</strong> solution can be done. This process eliminates the residual virus in the wound.</li>\n<li><strong>Suturing</strong> - <strong>Bite wounds</strong> are <strong>not sutured</strong> generally. If suturing is necessary, it is done after 24-48 hours under the cover of local infiltration of the rabies immunoglobulin which is generally done in category III wounds.</li>\n<li><strong>Other measures</strong> - Local antibiotics and tetanus toxoids should be given.</li>\n</ul>\n<p>Different wound categories for post-exposure prophylaxis:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Categories of wound</strong></td>\n<td><strong>Post-exposure prophylaxis</strong></td>\n</tr>\n<tr>\n<td><strong>Category I</strong> - touching or feeding animals, licks on intact skin</td>\n<td>None</td>\n</tr>\n<tr>\n<td><strong>Category II</strong> - nibbling of uncovered skin, minor scratches, or abrasions <br />without bleeding</td>\n<td>Immediate vaccination and <br />local treatment of the wound</td>\n</tr>\n<tr>\n<td><strong>Category III</strong>- single or multiple transdermal bites or scratches, licks on broken skin contacts with bats</td>\n<td>Immediate vaccination and <br />administration of rabies <br />immunoglobulin; local <br />treatment of the wound</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/392a54a2acd4467ea5911880db1f96b4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9404",
      "difficulty": "medium"
    },
    {
      "text": "Which is not included in the 4-pronged strategy for PPTCT (Prevention of Parent to Child Transmission of HIV )?",
      "choices": [
        {
          "id": 1,
          "text": "Prevention of unintended pregnancies among women living with HIV"
        },
        {
          "id": 2,
          "text": "Initiating pre-exposure prophylaxis in female sex workers "
        },
        {
          "id": 3,
          "text": "Primary prevention of HIV among women of childbearing age"
        },
        {
          "id": 4,
          "text": "Provide care, support, and treatment to women and their families living with HIV"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Initiating pre-exposure prophylaxis in female sex workers is not included in the 4-pronged strategy for PPTCT.</p>\n<p>The <strong>National PPTCT programme</strong> identifies <strong>four</strong> elements in preventing HIV transmission among women and children. These include the following: </p>\n<p><strong>Prong 1</strong>: <strong>Primary prevention of HIV (Option C)</strong>, especially among women of childbearing age - This can be achieved by the implementation of the general population-based HIV prevention strategy and the Adolescent Reproductive and Sexual Health (ARSH) programme. </p>\n<p><strong>Prong 2</strong>: <strong>Prevention of unintended pregnancies (Option A)</strong> among women living with HIV -This strategy aims at educating all HIV-positive women on available options of contraception and family planning methods. HIV-positive women should be assisted in making decisions regarding planning a pregnancy and childbirth by the staff of ICTC, ART centre and CSC. </p>\n<p><strong>Prong 3</strong>: <strong>Prevention of HIV transmission from pregnant women infected with HIV to their children</strong> - This includes linking HIV-positive pregnant mothers to ART centres for ART initiation, counselling for adherence to ART and safe sex practices, referral for plasma viral load between 32 and 36 weeks of pregnancy to determine the risk of HIV transmission to the baby and decision on the type of infant ARV prophylaxis. Institutional deliveries and ARV prophylaxis to their babies with infant feeding counselling </p>\n<p><strong>Prong 4</strong>: <strong>Provide care, support and treatment</strong> <strong>(Option D)</strong> to women living with HIV and to their children and families - This includes treatment support, feeding counselling, immunisation, and linking their children to the PPTCT centre for the care of HIV-exposed infants, including the EID programme.</p><hr><h3>Related Pearl: Prevention of parent to child transmission (PPTCT)</h3><p>Important provisions of PPTCT services for HIV:</p>\n<ul>\n<li>HIV counseling and testing for all pregnant women enrolled in antenatal care with &lsquo;opt out&rsquo; option.</li>\n<li>Lifelong ART i.e. <strong>Tenofovir (TDF) + Lamivudine (3TC)+ Dolutegravir (DTG)</strong> administration to all pregnant and breastfeeding HIV-infected women <strong>regardless of CD4 count and clinical stage</strong>.</li>\n<li>Institutional deliveries of HIV-infected mothers</li>\n<li>Care of associated conditions (STI/RTI, TB, opportunistic infections, hypertension, diabetes)</li>\n<li>Exclusive breastfeeding counseling</li>\n<li><strong>Plasma viral load testing</strong> at <strong>32&ndash;36 weeks of gestation</strong> to determine the risk of HIV transmission to the baby</li>\n<li aria-level=\"1\">Initiation of ARV in babies:<br />\n<ul>\n<li aria-level=\"2\">Low-risk infants: <strong>Syrup Nevirapine</strong> from <strong>birth till 6 weeks</strong> of age</li>\n<li aria-level=\"2\">High-risk infants: <strong>Syrup Nevirapine+ syrup Zidovudine</strong> either from <strong>birth till 6 weeks</strong> of age (exclusive replacement feeding) or from <strong>birth till 12 weeks</strong> of age (exclusive breastfeeding)</li>\n</ul>\n</li>\n<li>Nutrition counseling and psychosocial support to HIV-infected pregnant women</li>\n<li>Ensure <strong>co-trimoxazole prophylactic therapy (CPT)</strong> and early infant diagnosis using HIV-DNA PCR at 6 weeks of age onwards as per guidelines</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7427",
      "difficulty": "medium"
    },
    {
      "text": "You are the medical officer of a community health center and asked to find out the incidence rate of a disease in your community. Which of the following information cannot be derived from the incidence rate?",
      "choices": [
        {
          "id": 1,
          "text": "Possible etiology of the disease"
        },
        {
          "id": 2,
          "text": "Efficacy of therapeutic measures"
        },
        {
          "id": 3,
          "text": "Appropriate measures for disease control"
        },
        {
          "id": 4,
          "text": "Magnitude of disease in the community"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The magnitude of disease in the community cannot be assessed from the incidence rate.</p>\n<p>The <strong>incidence rate</strong> is defined as the number of <strong>new cases</strong> occurring in a <strong>defined</strong> <strong>population</strong> during a <strong>specified period</strong> of time. The incidence rate must be described in <strong>units of time</strong>. It is given by the formula:</p>\n<p><strong>Incidence = (Number of new cases of specific disease during a given time period / Population at risk in that period) x 1000.</strong></p>\n<div class=\"page\" title=\"Page 76\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Incidence measures the rate at which new cases are occurring in a population. The <strong>duration</strong> of a disease <strong>does</strong> <strong>not</strong> <strong>affect</strong> its <strong>incidence</strong>. The incidence is generally calculated in acute conditions. Uses of incidence rates as a health status indicator:</p>\n<div class=\"page\" title=\"Page 77\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Incidence can indicate the <strong>possible etiology</strong> of a disease. For example, a common infectious source would lead to a peak in the incidence of a disease.</li>\n<li>By studying the pattern of incidence of a disease, we can <strong>formulate measures</strong> to<strong> control</strong> the disease outbreak.</li>\n<li>A decrease in the incidence of a disease would reflect on the <strong>efficacy</strong> of a <strong>therapeutic measure</strong> taken to cure that disease.</li>\n<li>The <strong>distribution of disease</strong> can be determined by studying incidence with respect to age, geography, gender, socioeconomic standards, etc.</li>\n</ul>\n<p>The specialized incidence rates are:</p>\n<ul>\n<li><strong>Attack rate</strong> - It is an incidence rate expressed in <strong>percentage</strong>. It is used when the population is exposed to a risk factor for a short amount of time as in <strong>epidemics</strong>.  It reflects the number of new cases in the at-risk population due to the risk factor. </li>\n<li><strong>Secondary attack rate</strong> - It is defined as the number of cases that develop following exposure to the primary case within <strong>one incubation period</strong>.</li>\n</ul>\n<p>The<strong> magnitude of disease</strong> or health problems in the community is given by <strong>prevalence.</strong> It is also useful in <strong>identifying potential high-risk populations.</strong> Prevalence refers specifically to <strong>all current cases</strong> (old and new) existing at a given point in time, or over a period of time in a given population. <strong>Prevalence</strong> <strong>rates</strong> are useful for <strong>administrative</strong> and <strong>planning</strong> purposes like manpower needs, hospital beds needed, etc.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Incidence and Prevalence</h3><ul>\n<li><strong>Incidence</strong> <strong>in Epidemiology:</strong></li>\n</ul>\n<p><strong>Incidence</strong> is the number of <strong>new</strong> <strong>cases</strong> occurring in a defined population during a period of time. The incidence rate is expressed in <strong>person-time</strong> units, usually per 1000 per year. It is given by the following formula:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6f6cc8bc207d4585865b98fbe2659e6ax1280x274.JPEG\" alt=\"Pearl Image\"><p>It is generally used for <strong>acute illnesses. </strong>It provides insight into the <strong>effectiveness of health services and programs. </strong>Incidence can be determined from <strong>cohort studies and longitudinal studies.</strong></p>\n<p>The incidence rate of <strong>spells of sickness</strong> =  (Number of spells of sickness starting in the specified period/Mean number of people exposed to that risk in the specified time) x <strong>1000.</strong></p>\n<p>Special types of incidence rates:</p>\n<p>1.<strong> Attack rate: </strong>It is used when there is a risk for a limited period of time.</p>\n<p>2.<strong> Secondary attack rate: </strong>It is the number of exposed persons developing the disease within the range of incubation period following exposure to a primary case.</p>\n<ul>\n<li><strong>Prevalence in Epidemiology:</strong></li>\n</ul>\n<p>Prevalence is the proportion of all cases, <strong>old and new</strong>, of a particular disease at a given point in time or over a period of time in a given population. It is a <strong>proportion,</strong> not a rate or ratio. Prevalence is always expressed in <strong>percentage.</strong></p>\n<p>It is given by the formula:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e91eaa37efa84edd8f721ab2d87a9a13x1280x274.JPEG\" alt=\"Pearl Image\"><p>It is useful to determine the <strong>magnitude </strong>of health problems. It can be determined from <strong>cross-sectional studies.</strong></p>\n<p>Types:</p>\n<p>1. <strong>Point </strong>prevalence is the prevalence at a point in time. Usually, prevalence is point prevalence unless <strong>otherwise specified</strong>.</p>\n<p>2. <strong>Period</strong> prevalence is the prevalence over a period of time.</p>\n<p><strong>Relationship</strong> between<strong> Incidence</strong> and<strong> Prevalence:</strong></p>\n<p>Prevalence depends upon <strong>incidence and duration</strong>.</p>\n<p><strong>Prevalence</strong> = <strong>Incidence x Mean Duration</strong></p>\n<p><strong>Longer the duration</strong> of the disease, the greater the prevalence.</p>\n<p>Few examples:</p>\n<ul>\n<li>In acute diseases, because of rapid recovery/death prevalence will be relatively <strong>lower</strong> than incidence. This is because, in some diseases (eg. food poisoning), the disease is so short-lived, there are no \"old cases\".</li>\n<li>In chronic diseases like TB, prevalence will be <strong>higher</strong> than incidence.</li>\n<li>If a new treatment for a disease is effective, incidence does not change but <strong>prevalence decreases</strong> as the duration of disease decreases.</li>\n<li>If the treatment only prevents death but doesn’t cure the disease, it may cause a <strong>paradoxical increase</strong> in prevalence.</li>\n</ul><hr><h3>Related Pearl: Morbidity Measurements in Epidemiology</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5e17c2ec999e4412beacae58dadc5ea4x1280x1933.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2048",
      "difficulty": "hard"
    },
    {
      "text": "A 40-year-old woman whose mother is a known case of breast cancer undergoes a mammography every six months. The time advantage the woman achieves by doing so if diagnosed with breast cancer is represented by which of the following intervals in the given image?",
      "choices": [
        {
          "id": 1,
          "text": "1 to 3"
        },
        {
          "id": 2,
          "text": "1 to 2"
        },
        {
          "id": 3,
          "text": "2 to 3"
        },
        {
          "id": 4,
          "text": "Disease onset to 2"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The advantage gained&nbsp;by <strong>screening</strong> is the <strong>lead time</strong> which is represented by the time period between&nbsp;<strong>1 </strong>to<strong> 3</strong>.</p>\n<p><strong>Screening</strong> is the search for unrecognized diseases or defects in apparently healthy individuals by means of <strong>rapidly applicable</strong> tests or procedures. It must be done in conditions where there is a considerable&nbsp;<strong>time lag</strong>&nbsp;between the <strong>onset</strong> of the disease and the <strong>usual time</strong> of diagnosis (point 3 in the image). This ensures the success of any treatment in<strong> reversing</strong> the disease process.&nbsp;</p>\n<p>The time difference between the <strong>first possible point</strong> of diagnosis and the <strong>critical point</strong> of diagnosis is called&nbsp;<strong>screening time&nbsp;</strong>which is represented by the time interval 1 to 2 in the above image.&nbsp;</p>\n<p>The <strong>final critical point</strong> (point 2 in the image) is the stage beyond which treatment would be <strong>unsuccessful</strong> or there would be <strong>permanent damage</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad179d8f1b6141cc891755f350b78ca9x1280x1020.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Lead Time in Screening</h3><p>Lead time is the period between the <strong>first possible</strong> <strong>time</strong> of detection and the <strong>usual time</strong> of diagnosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b6e8bf826a364c7abb0006bc098eef63x1280x1020.JPEG\" alt=\"Pearl Image\"><p>Lead time is the advantage gained by screening. It helps in the early diagnosis and treatment of disease. Early treatment reduces the severity by reversing the disease process.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f33d215fa340494399132f223fc24dff.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1534",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old man is unemployed because he is unable to walk, as he lost his foot in an accident. The fact that he 'cannot walk' is described as _______",
      "choices": [
        {
          "id": 1,
          "text": "Disability"
        },
        {
          "id": 2,
          "text": "Handicap"
        },
        {
          "id": 3,
          "text": "Disorder"
        },
        {
          "id": 4,
          "text": "Impairment"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The fact that he <strong>cannot walk</strong> is explained by the <strong>disability</strong>, according to the concept given below.</p>\n<p><span><strong>Disease → Impairment → Disability → Handicap</strong></span></p>\n<ul>\n<li>Impairment is any loss or <strong>abnormality in normal structure or function</strong>.</li>\n<li>Disability is the <strong>inability to carry out</strong> normal actions due to impairment.</li>\n<li>Handicap is <strong>experiencing disadvantages</strong> due to disability and inability to discharge obligations normally.</li>\n</ul>\n<p>In the given example:</p>\n<ul>\n<li><strong>Accident</strong>: Disease (or disorder)</li>\n<li><strong>Loss of foot</strong>: Impairment (extrinsic or intrinsic)</li>\n<li><strong>Cannot walk</strong>: Disability (objectified)</li>\n<li><strong>Unemployed</strong>: Handicap (socialized)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3558",
      "difficulty": "medium"
    },
    {
      "text": "Identify the type of epidemic:",
      "choices": [
        {
          "id": 1,
          "text": "Single exposure, Point source epidemic"
        },
        {
          "id": 2,
          "text": "Multiple exposure, Point source epidemic"
        },
        {
          "id": 3,
          "text": "Propagated epidemic"
        },
        {
          "id": 4,
          "text": "Common source, continuous epidemic"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image given represents <strong>propagated epidemic</strong> which results from <strong>\"person to person transmission\".</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Single exposure / Point source epidemic</strong></td>\n<td><strong>Common source / Continuous epidemic</strong></td>\n<td><strong>Propagated epidemic</strong></td>\n</tr>\n<tr>\n<td><strong>A sharp rise and sharp fall</strong> in the number of cases</td>\n<td><strong>Sharp rise</strong> in the number of cases</td>\n<td><strong>Gradual rise and gradual fall </strong>over a long time</td>\n</tr>\n<tr>\n<td>Clustering of cases in a narrow interval of time such that all cases develop <strong>within one incubation period</strong> of the disease</td>\n<td>A fall in the number of cases is interrupted by \"<strong>secondary waves/peaks</strong>\"</td>\n<td>Results from \"person-to-person transmission\"</td>\n</tr>\n<tr>\n<td>\n<p>Eg: Food poisoning, Measles, Chickenpox, Cholera, Bhopal Gas tragedy</p>\n</td>\n<td>Eg: Contaminated well in a village, Prostitute in a gonorrhoea outbreak, Legionnaire's disease outbreak in Philadelphia</td>\n<td>Eg: HIV, TB </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The below image depicts the various epidemic curves.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/579ca139468e4ceaaf8e6744d1a047dex1280x3042.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/37a31237fc5b4d26aab362e0e139446f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2729",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions is not transmitted by the organism shown in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Kala azar"
        },
        {
          "id": 2,
          "text": "Oriental sore"
        },
        {
          "id": 3,
          "text": "Oraya fever"
        },
        {
          "id": 4,
          "text": "Trench fever"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Trench fever </strong>is not transmitted by sandflies. It is transmitted by<strong> lice</strong> and caused by<strong><em> Bartonella quintana</em></strong>.</p>\n<p><strong>Sandflies</strong> are involved in the transmission of <strong>Kala-azar </strong>(Visceral Leishmaniasis), <strong>oriental sore</strong>, <strong>Oroya fever, </strong>and<strong> Sandfly fever.</strong></p><hr><h3>Related Pearl: Arthropod- borne diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>Arthropod</strong></td>\n<td><strong>Disease transmitted</strong></td>\n</tr>\n<tr>\n<td>Anopheles mosquito</td>\n<td>Malaria, Filariasis</td>\n</tr>\n<tr>\n<td>Culex mosquito</td>\n<td>Bancroftian filariasis, Japenese encephalitis, West nile fever, Viral arthritis</td>\n</tr>\n<tr>\n<td>Aedes mosquito</td>\n<td>Yellow fever, Dengue, Chikungunya, filariasis, zika</td>\n</tr>\n<tr>\n<td>Mansoni Mosquito</td>\n<td>Filariasis, Chikungunya</td>\n</tr>\n<tr>\n<td>Housefly</td>\n<td>Typhoid and paratyphoid fever, diarrhea, dysentery, cholera, gastroenteritis, amoebiasis, helminthic infestations, poliomyelitis, conjunctivitis, trachoma, anthrax, yaws, etc.</td>\n</tr>\n<tr>\n<td>Sandfly (Phlebotomus)</td>\n<td>Kala-azar(Visceral Leishmaniasis), oriental sore, Oroya fever, Sandfly fever</td>\n</tr>\n<tr>\n<td>Tsetse fly</td>\n<td>Sleeping sickness(African Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Louse</td>\n<td>Epidemic typhus, relapsing fever, trench fever, pediculosis</td>\n</tr>\n<tr>\n<td>Rat flea</td>\n<td>Bubonic plague, endemic typhus(Murine Typhus), hymenolepis diminuta</td>\n</tr>\n<tr>\n<td>Black fly(Simulium)</td>\n<td>Onchocerciasis</td>\n</tr>\n<tr>\n<td>Reduviid bug(Kissing bug/triatominae)</td>\n<td>Chagas disease(American Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Hard tick (Ixodes species)</td>\n<td>Tick typhus, viral encephalitis, viral fevers, viral hemorrhagic fever,(e.g. Kyasanur forest disease), tularemia, tick paralysis, human babesiosis, lyme disease</td>\n</tr>\n<tr>\n<td>Soft Tick (Argas species)</td>\n<td>Q fever, relapsing fever, Kyasanur forest disease (KFD) (can be casued by hard tick as well)</td>\n</tr>\n<tr>\n<td>Trombiculid mite</td>\n<td>Scrub typhus, Rickettsial pox</td>\n</tr>\n<tr>\n<td>Itch mites</td>\n<td>Scabies</td>\n</tr>\n<tr>\n<td>Cyclops</td>\n<td>Guinea-worm disease, fish tapeworm (D. latum)</td>\n</tr>\n<tr>\n<td>Cockroaches</td>\n<td>Enteric pathogens</td>\n</tr>\n<tr>\n<td>Sand flea (Tunga penetrance, Jiggar, Chigoe flea)</td>\n<td> Tungiasis, Ulcer in the feetnails</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Sandfly</h3><ul>\n<li>They are also referred to as <strong>Phlebotomus.</strong></li>\n<li>They transmit diseases such as <strong>kala-azar</strong> (visceral leishmaniasis), Oriental sore, sandfly fever, and Oroya fever.</li>\n<li>They are generally smaller than mosquitoes and are <strong>hairy insects.</strong></li>\n<li>They like to dwell in cracks and crevices in walls during the daytime. They are active during the night (<strong>nocturnal pests</strong>).</li>\n<li>They do not fly for more than <strong>50 yards.</strong></li>\n<li>They can be <strong>controlled by insecticides&nbsp;</strong>and also by proper sanitation.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e7a4a6340edf44ae8550e78a19029e0fx1280x864.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Definitive and intermediate hosts of various parasites</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parasite</strong></p>\n</td>\n<td>\n<p><strong>Definitive host</strong></p>\n</td>\n<td>\n<p><strong>Intermediate host</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Protozoa</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmodium spp.</p>\n</td>\n<td>\n<p>Female Anopheles mosquito</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Babesia</p>\n</td>\n<td>\n<p>Tick</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leishmania</p>\n</td>\n<td>\n<p>Man, dog</p>\n</td>\n<td>\n<p>Sandfly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma brucei</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Tsetse fly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma cruzi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Triatomine bug</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toxoplasma gondii</p>\n</td>\n<td>\n<p>Cat</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cestodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia solium</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia saginata</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cattle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Echinococcus granulosus</p>\n</td>\n<td>\n<p>Dog</p>\n</td>\n<td>\n<p>Sheep, horses.</p>\n<p>Man is the accidental intermediate host.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciola hepatica</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciolopsis buski</p>\n</td>\n<td>\n<p>Man, pig</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Schistosoma spp.</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trichinella spiralis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Wuchereria bancrofti</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brugia malayi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dracunculus medinensis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cyclops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8776c91aae58418dad06b9f3c0b465be.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6102",
      "difficulty": "medium"
    },
    {
      "text": "As an epidemiologist, you are interested in studying largely subclinical diseases. Which of the following diseases would be appropriate to study?",
      "choices": [
        {
          "id": 1,
          "text": "Tetanus"
        },
        {
          "id": 2,
          "text": "Rubella"
        },
        {
          "id": 3,
          "text": "Measles"
        },
        {
          "id": 4,
          "text": "Rabies"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Rubella</strong> shows the <strong>iceberg phenomenon</strong> of disease and thus has a <strong>pre-symptomatic</strong> phase. So, it would be appropiate to study rubella as a vast majority of cases go <strong>unrecognized</strong> in the community.</p>\n<p>The iceberg phenomenon of diseases is <strong>not shown</strong> by diseases such as <strong>tetanus</strong>, <strong>rabies</strong>, and <strong>measles</strong>.</p>\n<p>Iceberg phenomenon is shown by:</p>\n<ul>\n<li>Polio</li>\n<li>Influenza</li>\n<li><strong>Rubella</strong></li>\n<li>Mumps</li>\n<li>Japanese Encephalitis</li>\n<li>Diphtheria</li>\n<li>Hepatitis A and B</li>\n<li>Tuberculosis</li>\n<li>Diabetes</li>\n<li>Malnutrition</li>\n<li>Hypertension</li>\n</ul>\n<p>Note: If a disease has <strong>more</strong> number of<strong> subclinical infections</strong>, it shows the <strong>iceberg phenomenon</strong> of disease depicted in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bc171ac344f4c69ae5e07529257efdcx1280x1252.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0521",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following describes correctly the route and dosage of the killed Japanese encephalitis vaccine under the National Immunization Schedule?\n",
      "choices": [
        {
          "id": 1,
          "text": "Intramuscular, 0.5 ml "
        },
        {
          "id": 2,
          "text": "Intradermal, 0.1 ml "
        },
        {
          "id": 3,
          "text": "Subcutaneous, 0.5 ml"
        },
        {
          "id": 4,
          "text": " Intramuscular, 0.1 ml"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Under the <strong>National Immunization Schedule (NIS)</strong>, administration of <strong>0.5ml</strong> of <strong>killed JE vaccine</strong> is via the <strong>intramuscular </strong>route.</p>\n<p>The <strong>Japanese encephalitis</strong> (JE) virus is transmitted by the bite of <strong>Culex </strong>mosquitoes, specifically <em>Culex tritaeniorhynchus</em> and <em>Culex vishnui</em> (common in India) species. They present with <strong>fever and headache</strong> in mild disease form and severe disease presents with <strong>rapid onset of high fever, headache, neck stiffness, disorientation, coma, seizures, spastic paralysis, </strong>and<strong> ultimately death.</strong></p>\n<p><strong>Killed JE vaccines</strong> (Inactivated <strong>SA 14-14-2</strong> cell culture-derived and inactivated Vero cell culture-derived) are gradually replacing live attenuated vaccines. This change is because the killed vaccines are reported to have <strong>better immunogenicity</strong> than the live attenuated vaccine.</p>\n<p>The <strong>SA 14-14-2 (live attenuated)</strong> vaccine is based on a stable neuro-attenuated strain of the JE virus with a Yellow Fever vaccine acting as a viral vector. Adverse effects of the vaccine include <strong>fever and rash.</strong></p>\n<p>The dosage of the vaccine is 0.5ml and the site of administration is as follows:</p>\n<ul>\n<li><strong>Live</strong> vaccine: <strong>Subcutaneous</strong>, left upper arm</li>\n<li><strong>Killed</strong> vaccine: <strong>Intramuscular</strong>, anterolateral side of left mid-thigh</li>\n</ul>\n<p>They can be administered to up to <strong>15 years</strong> of age with a <strong>month gap</strong> between the <strong>two doses.</strong></p>\n<p>The JE virus vaccine has been included in the National Immunization Schedule (NIS) to be administered in <strong>endemic </strong>areas (Uttar Pradesh, Assam, West Bengal, Karnataka) in two doses. The first dose is administered at <strong>9-12 completed months</strong>. The second dose is administered at <strong>16-24 months</strong>. The schedule however mentions the use of both live and killed vaccines.</p>\n<p>Note: According to the national immunization schedule, both live attenuated, killed-inactivated vaccines are now used for vaccination against the JE virus.</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7412",
      "difficulty": "medium"
    },
    {
      "text": "A newly pregnant woman from a rural area registered in the scheme shown below. Which of the following benefits would she receive under this scheme?",
      "choices": [
        {
          "id": 1,
          "text": "A cash incentive of 5000 rupees"
        },
        {
          "id": 2,
          "text": "At least 4 antenatal checkups and 6 homebased newborn care visits"
        },
        {
          "id": 3,
          "text": "Free checkup on 9th of every month"
        },
        {
          "id": 4,
          "text": "A cash incentive of 1400 rupees"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above image shows the logo of <strong>Pradhan Mantri Surakshit Matritva Abhiyan</strong> (PMSMA). Under this scheme, all pregnant women will receive a <strong>free checkup</strong> on the <strong>9th </strong>of<strong> every month</strong>.</p>\n<p>PMSMA aims to improve the quality and coverage of antenatal care, diagnostics, and counseling services. This is undertaken as part of the <strong>reproductive maternal neonatal child and adolescent health</strong> (RMNCH+A) strategy. Under PMSMA, a pregnant woman receives<strong> at least 1 check-up</strong> in her <strong>second</strong> or <strong>third trimester</strong> by a doctor in the PMSMA clinic, on the 9th of every month.</p>\n<p>After routine examination, pregnant women are categorized according to the risk factors, and different <strong>colored</strong> <strong>stickers</strong> are given as follows:</p>\n<ul>\n<li><strong>Green</strong> sticker: For women with <strong>no</strong> detected <strong>risk factor</strong></li>\n<li><strong>Red </strong>sticker<strong>: </strong>For women with<strong> detected risk factor</strong></li>\n</ul>\n<p>Other options:</p>\n<p>Option A: A cash incentive of <strong>5000 rupees</strong> is provided to all pregnant women and lactating mothers under <strong>Pradhan Mantri Matru Vandana Yojana</strong> (PMMVY) for the first living child of the family. This is subject to fulfillment of specific conditions.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fb4ae2bda8f546c8a2ffd9e15602f705x102x100.PNG\" alt=\"Explanation Image\"><p>Option B: At least 4 antenatal checkups and 6 home-based newborn care visits are provided under <span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;May 28th has been commemorated as the International Day of Action for Women’s Health, to create awareness regarding the sexual and reproductive health and rights of women worldwide.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33563519,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:6989903},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0,&quot;16&quot;:10,&quot;28&quot;:1}\"><strong>Surakshit Matritva Aashwasan</strong> (SUMAN). It is a new initiative for women and newborns where assured, dignified, respectful, and quality healthcare is provided <strong>free </strong>of<strong> cost.</strong>  It aims to<strong> end </strong>all<strong> preventable maternal </strong>and <strong>newborn deaths</strong>.</span></p>\n<p>Option D: A cash incentive of <strong>1400 rupees</strong> is provided to all pregnant women who underwent an institutional delivery in low-performing states under <strong>Janani Suraksha Yojana</strong> (JSY). This scheme is launched under NRHM (national rural health mission) to <strong>promote institutional delivery.</strong></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/527eee60bc6f4d25a950462d349ad1b2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2236",
      "difficulty": "medium"
    },
    {
      "text": "You were posted for screening of deafness in school children under your primary health center. Which type of screening is done in this scenario?",
      "choices": [
        {
          "id": 1,
          "text": "Prospective screening"
        },
        {
          "id": 2,
          "text": "Multiphasic screening"
        },
        {
          "id": 3,
          "text": "Prescriptive screening"
        },
        {
          "id": 4,
          "text": "Selective screening"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The type of<strong> screening </strong>done for <strong>deafness in school children</strong> is <strong>prescriptive screening</strong>. </p>\n<p><strong>Prescriptive screening</strong> is done for <strong>case detection</strong>. People are examined primarily for their <strong>own benefit</strong>. It may lead to the <strong>early identification </strong>of an <strong>unrecognized disease</strong>. Hence, appropriate treatment can be initiated immediately to decline the disease progression.</p>\n<p>Screening is initiated by medical and public health personnel and is not requested by a patient. Examples of prescriptive screening are:</p>\n<ul>\n<li>Screening of hemolytic disease in newborns</li>\n<li>Screening of infants for <strong>phenylketonuria</strong></li>\n<li>Screening of bacteriuria in pregnancy</li>\n<li>Screening of <strong>school children</strong> for visual and auditory defects</li>\n</ul>\n<p>Other options:</p>\n<p>Option A - <strong>Prospective screening</strong> is done for <strong>disease control</strong>. People are screened for the<strong> benefit</strong> of<strong> others</strong>. It may lead to an <strong>early</strong> <strong>diagnosis</strong> and permit more effective treatment. It also <strong>reduces</strong> the <strong>spread</strong> of infectious diseases in the community. Hence, reduces mortality associated with the disease. Examples of prospective screening are:</p>\n<ul>\n<li>Screening of<strong> immigrants</strong> from <strong>infectious diseases</strong> such as tuberculosis and syphilis to protect the citizens</li>\n<li>Screening for<strong> streptococcal infection</strong> to prevent rheumatic fever</li>\n<li>Screening of<strong> sex workers for HIV</strong> to prevent transmission of HIV to others</li>\n<li>Screening of <strong>COVID infection</strong> among the international passengers at the airport</li>\n</ul>\n<p>Option B - <strong>Multiphasic screening</strong> is the application of<strong> two or more screening tests</strong> in combination, to a large population at<strong> one time</strong>. It is not cost-effective and has shown no benefit in reducing the morbidity and mortality of the population.</p>\n<p>Option D - <strong>Selective screening</strong> is done in <strong>high-risk groups</strong>. It is one of the most <strong>effective </strong>screening tests. Example: <strong>Screening for diabetes</strong> in the other members of a family for a detected diabetes case since these diseases get aggregated in families.</p><hr><h3>Related Pearl: Validity of a Screening Test</h3><ul>\n<li><strong>Validity/ accuracy </strong>of a screening test depends upon the <strong>sensitivity, specificity,</strong> and<strong> predictive accuracy</strong> of the test.</li>\n<li>It represents the closeness to a true value/ actual value.</li>\n<li>These are the <strong>inherent properties</strong> of a screening test.</li>\n<li>P<strong>P</strong>V and N<strong>P</strong>V are <strong>dependent</strong> on the <strong>P</strong>revalence of disease.</li>\n<li>Sensitivity &amp; Specificity are independent of prevalence of disease.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62275b1d441443bc92db11bb3add523ex1280x959.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Formulae</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span>Sensitivity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TP</strong>&nbsp; &nbsp;&nbsp;</span></span><br /><span><strong>TP</strong> + FN</span></td>\n</tr>\n<tr>\n<td><span>Specificity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TN&nbsp; &nbsp;&nbsp;</strong></span><sub><br /></sub>FP + <strong>TN</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a positive test (<strong>P</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>P&nbsp; &nbsp;&nbsp;</strong></span><sub><br /></sub>T<strong>P</strong> + F<strong>P</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a negative test (<strong>N</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>N&nbsp; &nbsp;&nbsp;</strong>&nbsp;</span><sub><br /></sub>T<strong>N</strong> + F<strong>N</strong></span></td>\n</tr>\n<tr>\n<td><span>Percentage of false positives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FP&nbsp; &nbsp; &nbsp;</span><sub><br /></sub>FP + TN</span></td>\n</tr>\n<tr>\n<td><span>Percentage of false negatives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FN&nbsp; &nbsp; &nbsp;</span><sub><br /></sub>TP + FN</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>PPV</strong> varies <strong>directly</strong> with prevalence</li>\n<li><strong>NPV</strong> varies <strong>inversely</strong> with prevalence</li>\n</ul><hr><h3>Related Pearl: Lead Time in Screening</h3><p>Lead time is the period between the <strong>first possible</strong> <strong>time</strong> of detection and the <strong>usual time</strong> of diagnosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b6e8bf826a364c7abb0006bc098eef63x1280x1020.JPEG\" alt=\"Pearl Image\"><p>Lead time is the advantage gained by screening. It helps in the early diagnosis and treatment of disease. Early treatment reduces the severity by reversing the disease process.</p><hr><h3>Related Pearl: Cut-off points in diagnostic tests</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/77956c061f8a417f980dc92fa3b56592x1199x1136.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Highly <strong>sensitive</strong> test, when <strong>negative</strong>, <strong>rules out</strong> a disease. <strong>(Screening test)</strong></li>\n<li>Highly <strong>specific</strong> test, when <strong>positive</strong>, <strong>rules in</strong> a disease. <strong>(Confirmatory test)</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd3edf675b3f4e30a140e2ff769dc087x1200x1109.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/94e48ae863c74fbea0b8bfed13733accx1280x1199.JPEG\" alt=\"Pearl Image\"><p><strong>Sensitivity</strong> (True-positive rate): High sensitivity indicates low false-negative rate.</p>\n<p><strong>Specificity</strong>&nbsp;(True-negative rate): High specificity indicates low false-positive rate.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2956",
      "difficulty": "hard"
    },
    {
      "text": "Match the following levels of prevention with their most appropriate examples.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1. Primordial</td>\n<td>a. Screening children from economically weaker families for malnutrition.</td>\n</tr>\n<tr>\n<td>2. Primary</td>\n<td>b. Reconstructive surgery for patients with residual deformities due to leprosy.</td>\n</tr>\n<tr>\n<td>3. Secondary</td>\n<td>c. Educating children about the harmful effects of smoking.</td>\n</tr>\n<tr>\n<td>4. Tertiary</td>\n<td>d. Use of helmets and eye protection in factories.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-a, 2-c, 3-b, 4-d"
        },
        {
          "id": 2,
          "text": "1-c, 2-d, 3-a, 4-b"
        },
        {
          "id": 3,
          "text": "1-a, 2-d, 3-c, 4-b"
        },
        {
          "id": 4,
          "text": "1-c, 2-a, 3-d, 4-b"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct match is <strong>1-c, 2-d, 3-a, 4-b.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>1. Primordial</td>\n<td>C. Educating children about the harmful effects of smoking.</td>\n</tr>\n<tr>\n<td>2. Primary</td>\n<td>D. Use of helmets and eye protection in factories.</td>\n</tr>\n<tr>\n<td>3. Secondary</td>\n<td>A. Screening children from economically weaker families for malnutrition.</td>\n</tr>\n<tr>\n<td>4. Tertiary</td>\n<td>B. Reconstructive surgery for patients with residual deformities due to leprosy.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Primordial prevention</strong> <strong>prevents </strong>the<strong> emergence of risk factors</strong> themselves. The <strong>interventions </strong>revolve around trying to<strong> encourage children to adopt healthy lifestyles </strong>to prevent health issues in adulthood. Thus, educating children about the harmful effects of smoking is an example of primordial prevention. </p>\n<p>The use of <strong>helmets </strong>and <strong>eye protection in factories</strong> is an example of <strong>specific protection</strong> against industrial hazards. While the risk factors have emerged (working around dangerous machinery), the intervention is to prevent any injury. Thus, it comes under <strong>primary prevention</strong>. </p>\n<p><strong>Screening children </strong>from economically weaker families is an example of <strong>early diagnosis</strong>. This intervention identifies the children who have malnutrition as soon as possible, to begin treatment. Thus, it comes under <strong>secondary prevention</strong>.</p>\n<p><strong>Reconstruction surgery</strong> for leprosy patients is an<strong> intervention to rehabilitate patients</strong> and bring some extent of physical function back. It comes under <strong>disability limitation </strong>and <strong>rehabilitation</strong>, and thus, is a <strong>tertiary level of prevention</strong>.</p><hr><h3>Related Pearl: Levels of Prevention</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Primordial</strong></p>\n</td>\n<td>\n<p><strong>Primary</strong></p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phase of disease</strong></p>\n</td>\n<td>\n<p>Underlying socio-economic &amp; environmental conditions leading to causation</p>\n</td>\n<td>\n<p>Specific causal or risk factors</p>\n</td>\n<td>\n<p>Early stage of disease</p>\n</td>\n<td>\n<p>Late stage of disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Aim</strong></p>\n</td>\n<td>\n<p>Establish and maintain conditions that minimize hazards to health</p>\n</td>\n<td>\n<p>Reduce the incidence of disease</p>\n</td>\n<td>\n<p>Reduce prevalence by shortening duration</p>\n</td>\n<td>\n<p>Reduce number and impact of complications</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Actions</strong></p>\n</td>\n<td>\n<p>Inhibition of emergence of socio-economic, environmental and behavioural conditions</p>\n</td>\n<td>\n<p>Protection of personal and community health by eliminating risks</p>\n</td>\n<td>\n<p>Early detection and intervention to minimize disability</p>\n</td>\n<td>\n<p>Soften the impact of long-term disease and disability, minimize suffering</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Modes of Intervention</strong></p>\n</td>\n<td>\n<p>Health education</p>\n</td>\n<td>\n<p>Health promotion and specific protection</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Diagnosis and treatment</p>\n</td>\n<td>\n<p>Disability limitation and rehabilitation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Targets</strong></p>\n</td>\n<td>\n<p>Total population or select groups</p>\n</td>\n<td>\n<p>Total population or high risk individuals/groups</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Individuals/ Patients</p>\n</td>\n<td>\n<p>Patients</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8873",
      "difficulty": "easy"
    },
    {
      "text": "In a study that investigates the relationship between steroid contraceptives and breast cancer, there is found to be a strong association between age and breast cancer, resulting in a confounding bias. Which of the following is an approach to eliminate such an association?<div class='question-desc-html'><ol>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Restriction</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Randomization</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Blinding</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Pre-Stratification</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Deletion </span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3"
        },
        {
          "id": 2,
          "text": "1, 2, 4"
        },
        {
          "id": 3,
          "text": "3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 4, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div>The correct answer is <strong>1, 2, 4.</strong></div>\n<div> </div>\n<div>In the given study <strong>age</strong> is found to be a <strong>confounding factor</strong>. <strong>Confounding</strong> <strong>bias</strong> in the given study with age as a confounding factor can be eliminated by <strong>restriction, randomization, </strong>and<strong> <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">pre-</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">stratification</span></strong>. </div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">A<strong> confounding factor </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is defined as one </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>associated </strong>with<strong> both exposure and disease </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">and is distributed </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>unequally </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">in study and control groups. </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">In the given example, if the study is conducted without eliminating the confounding factor,</span></span> there is an unexpectedly strong association between the confounding factor (e.g.. age) and the disease (e.g., breast cancer)<br /><br /></div>\n<div> <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Techniques to eliminate confounding factors include:</span></div>\n<ul class=\"listtype-bullet listindent1 list-bullet1\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Randomization</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Matching</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Stratified randomization</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Restriction</span></li>\n</ul>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Randomization </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is the random allocation of the participants in </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>experimental </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>studies </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(Randomized</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> control trials) into the study group and control group.<br /><br /></span></div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Matching</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, which is usually done in </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>analytical </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>studies </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(for example, case-control</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> and cohort studies), is the process where the participants in two groups are matched based on factors such as age, gender, race, smoking status, etc. to eliminate the potential confounders.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Stratified randomization</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, which is also known as <strong>pre-</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>stratification </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">or blocking, is the process that combines both randomization and matching techniques. In this method, the participants are first grouped into subgroups that internally match with potential confounding factors such as age, race, gender, etc. An equal number of participants from each subgroup are then allocated to the study and control groups.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Restriction</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">: This method restricts the study to only those participants with particular characteristics. For example, a study can be restricted to participants of only one gender, race, age group, geographical area, disease severity, etc., thus eliminating the potential confounders.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Other options:</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Blinding and deletion do not eliminate confounding factors. Blinding is done to eliminate other biases <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">such as subject </span>bias, observer bias, or investigator bias.</span></div><hr><h3>Related Pearl: Bias in Epidemiological Studies</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of Bias</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>Methods to reduce it</strong></td>\n</tr>\n<tr>\n<td>Observer bias</td>\n<td>Differential ability to observe. A <strong>subjective</strong> bias.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Interviewer's bias</td>\n<td>Interviewer asking <strong>leading questions</strong> to the subjects. Or interviewing cases thoroughly than the controls.</td>\n<td>&nbsp;Double blinding</td>\n</tr>\n<tr>\n<td>Memory/ <strong>Recall</strong> bias</td>\n<td>Differential ability of cases and controls <strong>to recall</strong> a certain detail. An <strong>objective</strong> bias.</td>\n<td>Decrease time from exposure to follow-up</td>\n</tr>\n<tr>\n<td>Surveillance bias</td>\n<td>Active surveillance leads to an <strong>increased chance</strong> of <strong>identifying</strong> the event.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Reporting/ notification bias</td>\n<td>Diseases associated with <strong>stigma</strong> are <strong>reported less.</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Berkesonian</strong> bias</td>\n<td><strong>Hospital-based case-control studies.</strong> Occurs due to differential hospital admission rates.</td>\n<td>\n<p>Randomization or Matching&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Selection bias</td>\n<td>A <strong>sampling bias.</strong> Non-random allocation of subjects that do not represent the population</td>\n<td>Randomization or Matching</td>\n</tr>\n<tr>\n<td><strong>Hawthorne</strong> bias</td>\n<td><strong>Change</strong> in <strong>attitude/</strong> actions of the subjects under <strong>observation</strong></td>\n<td>Use placebo group</td>\n</tr>\n<tr>\n<td><strong>Confounding</strong> bias</td>\n<td><strong>Factors related</strong> to <strong>both exposure</strong> and <strong>outcome</strong> distort the effect of exposure on outcome</td>\n<td>Matching, cross-over studies, randomization, or stratification</td>\n</tr>\n<tr>\n<td>Attrition bias</td>\n<td>Participants <strong>lost to follow-up</strong> have a different prognosis than those who complete the study.</td>\n<td>Randomization</td>\n</tr>\n<tr>\n<td>Pygmalion bias</td>\n<td><strong>Researcher's</strong> high <strong>expectations</strong> in the efficacy of the treatment <strong>change</strong> the <strong>outcome</strong> of that treatment.</td>\n<td>Blinding</td>\n</tr>\n<tr>\n<td><strong>Neyman's/</strong> Prevalence-Incidence bias&nbsp;</td>\n<td>Occurs due to the <strong>selective survival</strong> in <strong>prevalent cases</strong> usually seen in <strong>fatal diseases.</strong> Very sick patients are automatically excluded because of their early death.</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Neyman&rsquo;s</strong> bias or prevalence-incidence bias example: a case-control study is carried out to study the relationship between tobacco smoking and acute myocardial infarction (AMI). The cases are interviewed one week after the coronary attack. If smoker patients with AMI die more frequently, the living cases will show a lower frequency of smoking, undervaluing the association between smoking and AMI. It has been shown that the bias occurs only if the risk factor influences mortality from the disease being studied.</p>\n<p><strong>Ecological fallacy</strong> results when characteristics of the group are assigned inappropriately to individuals.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8468",
      "difficulty": "medium"
    },
    {
      "text": "A new genetic syndrome has been defined, and its etiology is being debated by many scholars all around the world. A study is being performed, where you will describe the disease according to its distribution in terms of time, place and person, to formulate the hypothesis. In this study, you will do____.",
      "choices": [
        {
          "id": 1,
          "text": "Analysis and intervention"
        },
        {
          "id": 2,
          "text": "Analysis only"
        },
        {
          "id": 3,
          "text": "Observation, analysis, and intervention"
        },
        {
          "id": 4,
          "text": "Observation only"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>descriptive study</strong> is the study of choice for formulating an etiological hypothesis of a disease, where<strong> </strong>only <strong>observation </strong>is done.</p>\n<p>Types of epidemiological study:</p>\n<ol>\n<li>Observational study</li>\n</ol>\n<ul>\n<li>\n<ul>\n<li>Descriptive studies (hypothesis formulation)</li>\n<li>Analytical studies (hypothesis testing)</li>\n</ul>\n</li>\n</ul>\n<p>     2. Experimental studies/Intervention study (hypothesis confirmation)</p>\n<p>A descriptive study is undertaken to <strong>formulate an etiological hypothesis</strong> for a given disease. On the other hand, an <strong>analytical study </strong>is performed to<strong> test the hypothesis </strong>(i.e. to accept or reject the hypothesis).</p>\n<p><strong>Descriptive study:</strong></p>\n<ul>\n<li>Descriptive studies are limited to the <strong>description of a disease</strong>, including its etiology, pathogenesis, and occurrence, in a population.</li>\n<li>Diseases of <strong>unknown etiology or new diseases</strong> can be studied with descriptive epidemiology.</li>\n<li>There is <strong>no intervention</strong> in this type of study—it is merely <strong>observational</strong>.</li>\n<li>The diseases are described on the basis of their <strong>distribution</strong> in terms of <strong>time, place, and </strong>person, and a <strong>hypothesis </strong>is formed.</li>\n<li>This hypothesis is then tested using other types of studies.</li>\n<li>Studies like <strong>longitudinal and cross-sectional studies </strong>are used for the measurement of the disease being investigated.</li>\n</ul><hr><h3>Related Pearl: Types of Epidemiological Study Designs</h3><p><strong>Types of Epidemiological Study Designs</strong></p>\n<p>The flow chart below gives a glance into the types of epidemiological study designs and where they are generally used.</p>\n<p><strong>Note:</strong>&nbsp;<strong>Descripitve study</strong> is used to <strong>formulate</strong> aetiological hypothesis of a disease. Whereas <strong>analytical study</strong> is used to <strong>test</strong> the hypothesis (i.e to accept or reject the hypothesis).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8bf47c838ad64276ab706c700cc1758cx1280x2995.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6750",
      "difficulty": "medium"
    },
    {
      "text": "You are part of a research programme for COVID-19 and are asked to define the median incubation period. How will you define it?",
      "choices": [
        {
          "id": 1,
          "text": "Interval between onset of symptoms in primary and secondary cases"
        },
        {
          "id": 2,
          "text": "Time required for 50% of cases to occur following exposure"
        },
        {
          "id": 3,
          "text": "Interval between exposure and the occurrence of the first symptom"
        },
        {
          "id": 4,
          "text": "Time required for the start of pathogenesis following exposure"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> median incubation period</strong> is the time required for<strong> 50%</strong> of the <strong>cases</strong> to occur <strong>following exposure</strong>. The median incubation period of <strong>COVID-19</strong> of approximately<strong> 5 days</strong>.          </p>\n<p><strong>Incubation period</strong> is the <strong>time</strong> interval <strong>between invasion</strong> of the infectious agent and the appearance of the<strong> first symptom</strong> or <strong>sign</strong> in the body. It is termed as the latent period in non-infectious diseases.</p>\n<p>Incubation period depends upon:</p>\n<ul>\n<li aria-level=\"1\">Generation time of pathogen</li>\n<li aria-level=\"1\">Portal of entry</li>\n<li aria-level=\"1\">Infective dose</li>\n<li aria-level=\"1\">Individual susceptibility</li>\n</ul>\n<p>Incubation period is useful for :</p>\n<ul>\n<li aria-level=\"2\"><strong>Tracing</strong> the source of infection and contacts.</li>\n<li aria-level=\"2\">Determining the period of surveillance or <strong>quarantine</strong>.</li>\n<li aria-level=\"2\">Planning<strong> immunization</strong>.</li>\n<li aria-level=\"2\"><strong>Identification</strong> of <strong>point source</strong> or propagated epidemics.</li>\n<li aria-level=\"2\">Determining the <strong>prognosis</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6720",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are health care delivery indicators, except _______.",
      "choices": [
        {
          "id": 1,
          "text": "Population per trained birth attendant"
        },
        {
          "id": 2,
          "text": "Population-bed ratio"
        },
        {
          "id": 3,
          "text": "Bed turnover ratio"
        },
        {
          "id": 4,
          "text": "Doctor-nurse ratio"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Bed turnover ratio </strong>is an example of <strong>utilization rates</strong> of health services, not a health care delivery indicator.</p>\n<p>The provision of health care and the equity of distribution of health resources in different parts of the country are reflected by <strong>health care delivery indicators</strong>.</p>\n<p>Examples are:</p>\n<ul>\n<li>Doctor-population ratio</li>\n<li><strong>Doctor-nurse ratio (option D)</strong></li>\n<li><strong>Population-bed ratio (option C)</strong></li>\n<li>Population per health/ subcentre</li>\n<li><strong>Population per trained birth attendant (option A)</strong></li>\n</ul>\n<p>Utilization of services is expressed as the proportion of <strong>people in need</strong> of a service <strong>who receive it</strong> in a given period. It is considered to be indicative of the health status of the population.</p>\n<p>The following are <strong>utilization rates:</strong></p>\n<ul>\n<li>The proportion of infants immunized against 9 diseases in the expanded program on immunization (EPI)</li>\n<li>The proportion of women receiving antenatal care and supervised delivery </li>\n<li>Percentage of population using family planning methods</li>\n<li>Bed occupancy rate</li>\n<li>The average length of stay</li>\n<li><strong>Bed turnover ratio</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD9031",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not an initiative introduced under the national health program represented by the emblem below?",
      "choices": [
        {
          "id": 1,
          "text": "Nikusth"
        },
        {
          "id": 2,
          "text": "Meena"
        },
        {
          "id": 3,
          "text": "Sparsh"
        },
        {
          "id": 4,
          "text": "Sapna"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image is the emblem of the <strong>National Leprosy Eradication Programme </strong>(NLEP). Meena is not an initiative introduced under NLEP. </p>\n<p><strong>Meena</strong> is a nine-year-old girl, who is the symbol of <strong>UNICEF's</strong> <strong>Girl Empowerment programme</strong> to impart important messages on gender, child rights, education, health and development in the South Asian region.</p>\n<p><strong>National Leprosy Eradication Programme (NLEP) </strong>is a program of the <strong>Ministry </strong>of<strong> Health</strong> and<strong> Family Welfare</strong>, the government of India. Characteristics of the NLEP emblem:</p>\n<ul>\n<li>The <strong>lotus</strong> in the NLEP emblem<strong> </strong>symbolizes beauty and purity.</li>\n<li>A <strong>partially affected thumb,</strong> a <strong>normal forefinger,</strong> and the <strong>shape of a house </strong>symbolize that leprosy can be cured and that a patient with leprosy can be a useful member of society.</li>\n<li>The <strong>rising</strong> <strong>sun</strong> symbolizes <strong>hope </strong>and <strong>optimism</strong>.</li>\n<li>The emblem captures the spirit of hope and positivity in the eradication of leprosy.</li>\n</ul>\n<p>The vision of the NLEP is '<strong>Leprosy-free India</strong>'. <strong>Disability prevention</strong> and <strong>medical rehabilitation</strong> (DPMR) is the priority of the programme. The mission<strong> </strong>of  NLEP is to provide <strong>quality services free of cost</strong> to all people through the integrated healthcare system.</p>\n<p><strong>Nikusth </strong>(Option A)<strong> </strong>is a real-time <strong>web-based system</strong> for data management for <strong>leprosy</strong> cases. It is a software for <strong>monitoring</strong> leprosy patients,<strong> </strong>with a <strong>patient tracking mechanism</strong> launched by the Health &amp; Family Welfare Minister Government of India.</p>\n<p><strong>Sparsh Campaign </strong>(Option C) was introduced in 2017 on the occasion of Anti-Leprosy Day (observed on the last Sunday of January) to promote awareness. NLEP introduced this campaign in order to address the issue of the high level of <strong>stigma</strong> attached to leprosy and to<strong> increase awareness</strong> about various aspects of leprosy.</p>\n<p><strong>Sapna</strong> (Option D) is the <strong>mascot<em> </em></strong>designed and developed using a <strong>local school-going girl</strong> who will help to <strong>spread awareness</strong> in the community. The posters below depict the role play by <strong>Sapna</strong>:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/343729693bfd4e6c94ca9f39d46fa187x966x524.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ccbbc6fed7864797acc42016b94e8afc.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8637",
      "difficulty": "medium"
    },
    {
      "text": "You were enquired about the given logo and its main objectives during your rural postings. Which among the following is not included under the main objectives of this scheme?",
      "choices": [
        {
          "id": 1,
          "text": "Improvement in emergency newborn care"
        },
        {
          "id": 2,
          "text": "Improve the health and nutritional status of lactating mothers"
        },
        {
          "id": 3,
          "text": "Reduction in the incidence of their mortality and school dropout"
        },
        {
          "id": 4,
          "text": "Aid in psychological and social development of the child"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The logo in the given image is of the <strong>Integrated Child Development Scheme (ICDS)</strong>. Among the given options,<strong> improvement in emergency newborn care</strong> is <strong>not</strong> included under the main objectives of ICDS. <strong>Emergency newborn care</strong> is a part of the <strong>Reproductive and Child Health Programme</strong> (RCH), the <strong>National Health Mission</strong> (NHM) and the <strong>National Rural Health Mission </strong>(NRHM).</p>\n<p>The <strong>main objectives </strong>of the <strong>ICDS </strong>scheme are :</p>\n<ul>\n<li>Improve the <strong>health</strong> and <strong>nutritional status</strong> of children between <strong>0–6 years</strong>, <strong>pregnant </strong>and <strong>lactating mothers </strong>(Option B)</li>\n<li><strong>Reduction</strong> in the incidence of their <strong>mortality</strong> and <strong>school dropout </strong>(Option C)</li>\n<li>Provision of a firm foundation for the proper <strong>psychological, physical </strong>and <strong>social development </strong>of the child (Option D)</li>\n<li>Enhancement of the <strong>maternal education</strong> and capacity to look after her health and nutrition and that of her family</li>\n<li>Effective <strong>coordination of the policy </strong>and <strong>implementation </strong>among various departments and <strong>programmes </strong>aimed to <strong>promote child development</strong></li>\n</ul>\n<p>The World's largest community-based programme is the Integrated Child Development Services (ICDS) scheme. The scheme is targeted at children up to the age of 6 years, pregnant and lactating mothers and women 16–44 years of age. The scheme is aimed to improve the health, nutrition and education of the target community.</p><hr><h3>Related Pearl: Integrated child development services (ICDS)</h3><p><strong>Integrated child development services (ICDS): </strong>Package of services provided include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Beneficiary</strong></td>\n<td><strong>Services</strong></td>\n</tr>\n<tr>\n<td><strong>Pregnant women</strong></td>\n<td>\n<ul>\n<li>Health check up</li>\n<li>Tetanus immunization</li>\n<li>Supplementary nutrition</li>\n<li>Nutrition and health education</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Nursing mothers</strong></td>\n<td>\n<ul>\n<li>Health check up</li>\n<li>Supplementary nutrition</li>\n<li>Nutrition and health education</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Other women 15-45 years</strong></td>\n<td>\n<ul>\n<li>Nutrition and health education</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Children &lt;3 years</strong></td>\n<td>\n<ul>\n<li>Supplementary nutrition</li>\n<li>Immunization</li>\n<li>Health check up</li>\n<li>Referral services</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Children 3-6 years of age</strong></td>\n<td>\n<ul>\n<li>Supplementary nutrition</li>\n<li>Immunization</li>\n<li>Health check up</li>\n<li>Referral services</li>\n<li>Non formal education &nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Adolescent girls 11 -18 years</strong></td>\n<td>\n<ul>\n<li>Nutrition programme for adolescent girls</li>\n<li>Kishori shakti yojana</li>\n<li>Nutrition and &nbsp;heath education</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The logo of the ICDS is given below:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9cf9277a541c4877b367ef7957dd0d74x720x697.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/19b0e499a7074d8c90cc852e308971df.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7411",
      "difficulty": "medium"
    },
    {
      "text": "Results of various studies carried out to study the role of smoking in breast cancer are plotted below. Which of these studies are statistically insignificant?",
      "choices": [
        {
          "id": 1,
          "text": "D, E"
        },
        {
          "id": 2,
          "text": "B only"
        },
        {
          "id": 3,
          "text": "A, B, C"
        },
        {
          "id": 4,
          "text": "A, B, C, D, E"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image shown is that of a <strong>forest plot</strong> used for plotting the results of a <strong>meta-analysis. </strong>Any <strong>study </strong>whose confidence intervals <strong>touch</strong> the \"<strong>line of no effect</strong>\" is considered <strong>statistically insignificant. </strong>In this given plot <strong>Studies A, B, and C </strong>are touching the line of no effect and hence are statistically insignificant.</p>\n<p>A <strong>forest plot/blobbogram </strong>is used to present the results of a <strong>meta-analysis.</strong> It allows the results to be seen at a glance, with ready identification of outliers. Each study is represented as a rectangle and a horizontal line. The size of the rectangle represents the sample size of the study. The horizontal line on either side of the result shows the 95% confidence interval surrounding the point estimate.</p>\n<p>The vertical solid line is the <strong>“line of no effect,”</strong> where there is no difference between having the risk factor and the absence of the risk factor. (<strong>i.e., a risk ratio of zero</strong>). If any study touches this line such a study is statistically insignificant.</p>\n<p>In other words, when the confidence intervals of a <strong>study include an Odds Ratio of 1.0</strong>, that study is <strong>statistically insignificant</strong>. A forest plot also compares individual studies, for deciding whether a drug is significantly better than a placebo or not.</p><hr><h3>Related Pearl: Forest Plot</h3><ul>\n<li>A <strong>forest plot</strong> is used to present the results of a <strong>meta-analysis.</strong></li>\n<li>It is also called <strong>blobbogram.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01f09b9b2dbb44fc90c6a6bb84df981ax1125x727.PNG\" alt=\"Pearl Image\"><p>Interpretation of forest plots:&nbsp;</p>\n<ul>\n<li aria-level=\"1\">The <strong>rectangles</strong> represent the single studies</li>\n<li aria-level=\"1\">The <strong>size of the rectangle</strong> is proportional to the sample size</li>\n<li aria-level=\"1\">The <strong>horizontal line on either side</strong> - confidence interval, the longer the lines, the wider the confidential interval, the less reliable the study results</li>\n<li aria-level=\"1\">The <strong>vertical solid line</strong> - the &ldquo;line of no effect\", which represents the odds ratio or relative risk. If it is the odds ratio, then the vertical line would be at 1. No difference between the intervention and the placebo (i.e., <strong>a risk ratio of 1</strong>).&nbsp;</li>\n<li aria-level=\"1\">The <strong>location of the result</strong> - whether it favours the intervention (the statin drug) or not</li>\n<li aria-level=\"1\">A <strong>diamond</strong> shows the overall pooled result where all the individual studies are combined together and averaged</li>\n<li aria-level=\"1\"><strong>Lateral corners</strong> of the diamond represent the confidence interval, if these corners do not cross 'the line of no effect', then there is an overall statistically significant effect. If the diamond touches the vertical line, the overall result is not statistically significant.</li>\n<li>The <strong>vertical dashed line</strong> represents the <strong>overall pooled estimate</strong> which represents the <strong>meta-analysed measure of effect</strong>.</li>\n</ul>\n<p>Let's understand with an example -&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5b5dee4fbd514313a94da59b6f5366a4x1280x1200.JPEG\" alt=\"Pearl Image\"><ul>\n<li aria-level=\"1\">For <strong>study A</strong>- it has a wide horizontal line that crosses the line of null effect with a black box that is to the right of the vertical line. This most likely demonstrates a small scale study with few participants where the point estimate result favours the control used in the study. But because the study contains the null value in its 95% confidence interval, it is likely to have a p-value &gt;0.05 and not be statistically significant.</li>\n<li aria-level=\"1\">For <strong>study B</strong>- it has quite a narrow line that does not cross the line of null effect with a black box that is to the left of the vertical line and is bigger than study A. This most likely demonstrates a larger study with more participants compared to study A, where the result favours the intervention used. Because the 95% confidence interval does not contain the null value, this study is likely to have a p-value &lt;0.05 and hence the differences observed in the study can be regarded as statistically significant.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7e5200be4acc47749527e8dc8e7a39fa.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9680",
      "difficulty": "medium"
    },
    {
      "text": "An enthusiastic researcher found a positive correlation between the incidence of respiratory problems and the rising pollution in a district. He collected data from the district hospitals and the pollution control board. What is the type of study done here?",
      "choices": [
        {
          "id": 1,
          "text": "Ecological study"
        },
        {
          "id": 2,
          "text": "Case control study"
        },
        {
          "id": 3,
          "text": "Randomized control trial"
        },
        {
          "id": 4,
          "text": "Cohort study"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The study described above is an example of an <strong>ecological study.</strong></p>\n<p>The ecological study is a type of analytical study that analyzes the health status and its relation with other variables. It is also called <strong>correlational study</strong>, and it uses <strong>population</strong> as a <strong>unit </strong>of<strong> study</strong>.</p>\n<p>In the given scenario, the study was done with the district population, from which we can infer that the <strong>population</strong> was taken as the unit of the study. <span>Also, the study was done to </span><strong>correlate</strong><span> the incidence of respiratory problems and pollution in the existing community.</span></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of epidemiological study</strong></td>\n<td><strong>Unit of study</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Analytical studies (hypothesis testing)</strong></p>\n</td>\n<td>   </td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cohort study/ Follow up study</li>\n</ul>\n</td>\n<td>Individual</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Case-control study</li>\n</ul>\n</td>\n<td>Individual</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cross-sectional study/ Prevalence study</li>\n</ul>\n</td>\n<td>Individual</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Ecological study/ Correlational study</li>\n</ul>\n</td>\n<td>Population</td>\n</tr>\n<tr>\n<td>\n<p><strong>Experimental studies (hypothesis confirmation)</strong></p>\n</td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Randomized control trial/ Clinical trials</li>\n</ul>\n</td>\n<td>Patients</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Field trial</li>\n</ul>\n</td>\n<td>Healthy people</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Community trial</li>\n</ul>\n</td>\n<td>Community</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of Epidemiological Study Designs</h3><p><strong>Types of Epidemiological Study Designs</strong></p>\n<p>The flow chart below gives a glance into the types of epidemiological study designs and where they are generally used.</p>\n<p><strong>Note:</strong>&nbsp;<strong>Descripitve study</strong> is used to <strong>formulate</strong> aetiological hypothesis of a disease. Whereas <strong>analytical study</strong> is used to <strong>test</strong> the hypothesis (i.e to accept or reject the hypothesis).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8bf47c838ad64276ab706c700cc1758cx1280x2995.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Case Control Study</h3><p>In a <strong>case-control</strong> study, progression is from <strong>effect </strong>(disease) to<strong> cause</strong>&nbsp;(exposure) as the outcome or disease has already occurred. It is also called a&nbsp;<strong>retrospective</strong> study.</p>\n<p><strong>Design </strong>of case-control study:</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/54361314f5e0423d9bef0e4acae144a0x1280x1242.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Steps of case control study:</strong>\n<ul>\n<li>Selection of cases and controls</li>\n<li>Matching</li>\n<li>Measurement of exposure</li>\n<li>Analysis in the form of exposure rates, risk ratio, and odds ratio</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Advantages of case control study:</strong>\n<ul>\n<li>Easy to carry out, rapid and inexpensive</li>\n<li>Requires few subjects, no risk to subjects</li>\n<li>Used to investigate rare diseases</li>\n<li>Different etiological factors can be studied and risk factors can be identified</li>\n<li>No attrition problems, minimal ethical problems</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Disadvantages&nbsp;of case control study:</strong>\n<ul>\n<li>Relies on memory or past records giving rise to bias</li>\n<li>Selection of appropriate control groups is difficult</li>\n<li>Incidence cannot be measured</li>\n<li>Does not distinguish between causes and associated factors</li>\n<li>Not suited for evaluation of therapy or prophylaxis</li>\n<li>Representativeness of the cases and controls is often inadequate</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Cohort Study</h3><ul>\n<li>A <strong>cohort study</strong> progresses from <strong>cause</strong> (exposure) <strong>to effect</strong> (disease).</li>\n<li>It is also known as <strong>forward-looking </strong>study, <strong>incidence </strong>study,<strong> prospective </strong>study, and<strong> longitudinal </strong>study.</li>\n<li><strong>Design of a cohort study:</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ea236bdd083460eaa50179f47f0948dx1280x1373.JPEG\" alt=\"Pearl Image\"><ul>\n<ul>\n<li><strong>Types of cohort study:</strong>\n<ul>\n<li>Prospective (concurrent) cohort studies</li>\n<li>Retrospective (historical) cohort studies</li>\n<li>Combination cohort studies</li>\n</ul>\n</li>\n<li><strong>Steps of cohort study:</strong>\n<ul>\n<li>Selection of study subjects</li>\n<li>Obtaining data on exposure</li>\n<li>Selection of comparison groups</li>\n<li>Follow-up</li>\n<li>Analysis in terms of incidence rates and estimation of risk</li>\n</ul>\n</li>\n<li><strong>Advantages of cohort study:</strong>\n<ul>\n<li>Incidence can be calculated</li>\n<li>Several possible outcomes related to exposure can be studied at the same time</li>\n<li>Provides direct estimate of relative risk</li>\n<li>Calculation of dose-response ratio</li>\n<li>Minimization of certain biases</li>\n</ul>\n</li>\n<li><strong>Disadvantages of cohort study:</strong>\n<ul>\n<li>Cannot use for uncommon diseases</li>\n<li>Expensive, requires a large population and&nbsp;longer time</li>\n<li>Many common administrative and ethical problems</li>\n<li>High attrition and selection of subjects is difficult</li>\n<li>Dynamism of diagnostics is difficult to incorporate</li>\n<li>Tends to alter the behaviour of subjects known as&nbsp;<strong>Hawthorne effect</strong>.</li>\n</ul>\n</li>\n</ul>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3469",
      "difficulty": "medium"
    },
    {
      "text": "An 8-month-old child comes in contact with an active tuberculosis case. His parents take him to a pulmonologist. The child undergoes investigations and active TB is ruled out. The doctor recommends tuberculosis preventive treatment (TPT). Which of the following regimens does the child take as TPT?",
      "choices": [
        {
          "id": 1,
          "text": "6-months weekly isoniazid"
        },
        {
          "id": 2,
          "text": "3-month weekly isoniazid and rifapentine"
        },
        {
          "id": 3,
          "text": "6-months daily isoniazid"
        },
        {
          "id": 4,
          "text": "3-month daily isoniazid and rifapentine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The regimen for tuberculosis preventive treatment (TPT) for the <strong>8-month-old child</strong> in the given scenario is <strong>6 months of daily isoniazid.</strong></p>\n<p>The following TPT treatment options are recommended under National Tuberculosis Elimination Program (NTEP) once active TB has been ruled out:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Target Population</strong></td>\n<td><strong>Treatment options</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>People living with HIV (adults and children &gt;12 months)</li>\n<li>Infants &lt;12 months in contact with active TB</li>\n<li><strong>HHC </strong>(Household contact)<strong> (below 5 years) of pulmonary tuberculosis patients.</strong></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>6-months daily isoniazid</strong> (6H)</li>\n<li>3-month weekly isoniazid and rifapentine(3HP) in persons <strong>older than 2 years.</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HHC(5 years and above) of pulmonary TB patients (testing would be offered whenever available)</td>\n<td>\n<ul>\n<li>3-month weekly isoniazid and rifapentine (3HP)</li>\n<li>6-months daily isoniazid (6H)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Children/adults on immunosuppressive<br />therapy, silicosis, anti-TNF treatment, dialysis,<br />transplantation</td>\n<td>\n<ul>\n<li>3-month weekly isoniazid and rifapentine (3HP)</li>\n<li>6-months daily isoniazid (6H)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Dose of isoniazid : </p>\n<ul>\n<li>Age 10 years &amp; older: 5 mg/kg/day</li>\n<li>Age &lt;10 years: 10 mg/kg/day (range, 7–15 mg)</li>\n</ul>\n<p>The choice of regimen will be guided by the availability of the drugs and the tolerability profile of the patients.</p><hr><h3>Related Pearl: Diagnostic algorithm for Pulmonary TB – National Tuberculosis Elimination Programme (NTEP) 2020 Guidelines</h3><p>Any case of&nbsp;<strong>presumptive pulmonary TB</strong>&nbsp;should undergo <strong>sputum examination + chest X-ray + CB-NAAT</strong></p>\n<ul>\n<li>If sputum and chest X-ray normal:<strong> rule out TB and refer</strong></li>\n<li>If sputum is positive and CB NAAT is positive:<strong>&nbsp;microbiologically confirmed case of TB</strong></li>\n</ul>\n<p>The following protocol is used for <strong>CB-NAAT testing:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e8d17e5087654b588b4b519b350acb71x1280x2558.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: ATT Regimen for TB Patients</h3><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases. <br />All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2><strong><span>Classification based on drug resistance. </span></strong></h2>\n<p><span>The<strong> </strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. </li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2> </h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> or <strong>pre-XDR-TB</strong> ( MDR/RR-TB and resistance to fluoroquinolones). </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br /></strong></li>\n</ol>\n</td>\n<td>Pregnant and lactating women</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>Pa: Pretomanid</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0784",
      "difficulty": "medium"
    },
    {
      "text": "Rashtriya Bal Swasthya Karyakram (RBSK) aims to provide Child Health Screening and Early Intervention Services for children aged 0-18 years. Which of the following health conditions is not included under RBSK?\n",
      "choices": [
        {
          "id": 1,
          "text": "Neonatal jaundice"
        },
        {
          "id": 2,
          "text": "Congenital cataract"
        },
        {
          "id": 3,
          "text": "Developmental dysplasia of the hip"
        },
        {
          "id": 4,
          "text": "Congenital deafness"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Neonatal jaundice </strong>is <strong>not</strong> included under RBSK.</p>\n<p><strong>Rashtriya Bal Swasthya Karyakram (RBSK)</strong> is an initiative by the Indian government to screen children from birth up to 18 years of age for 4 'D's: <strong>Defects at birth, Diseases in children, Deficiency conditions, and Developmental delays including disabilities</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Defects at birth</strong></td>\n<td><strong> Deficiency conditions</strong></td>\n<td><strong>Diseases in children</strong></td>\n<td><strong>Developmental delays </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Neural tube defect</li>\n<li>Down’s syndrome</li>\n<li>Cleft lip and palate</li>\n<li>Talipes</li>\n<li><strong>Developmental dysplasia of the hip</strong></li>\n<li><strong>Congenital cataract</strong>, <strong>congenital deafness</strong>, congenital heart disease</li>\n<li>Retinopathy of prematurity</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Anemia especially severe anemia</li>\n<li>Vitamin A deficiency</li>\n<li>Vitamin D deficiency</li>\n<li>Severe acute malnutrition</li>\n<li>Goitre</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Scabies, fungal infections, and eczema</li>\n<li>Otitis media</li>\n<li>Rheumatic heart disease</li>\n<li>Reactive airway disease</li>\n<li>Dental caries</li>\n<li>Convulsive disorders</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Vision, hearing, and neuro-motor impairment</li>\n<li>Motor, cognitive, and language delay</li>\n<li>Autism</li>\n<li>Learning disorder</li>\n<li>Attention deficit hyperactivity disorder</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>This program is designed to provide comprehensive healthcare through the early detection and management of these conditions. Conditions such as congenital cataracts, developmental dysplasia of the hip, and congenital deafness are explicitly targeted under this program due to their potential for significant impact on long-term health if not addressed early.</p>\n<p><strong>Neonatal jaundice</strong>, while common, is typically a transient condition that resolves within the first week or two of life in the majority of neonates. It is usually managed in the immediate neonatal period and often does not require long-term follow-up unless it indicates an underlying pathology, which is not the primary focus of RBSK. Thus, neonatal jaundice is not specifically included in the RBSK, which focuses more on long-term and chronic conditions that can affect a child's development and quality of life.</p>\n<p>Option B: <strong>Congenital cataracts</strong> are included under RBSK as they can lead to blindness if not treated early; hence, they are a focus for early screening and intervention.</p>\n<p>Option C: <strong>Developmental dysplasia of the hip</strong> is also included as it can cause lifelong disability and is ideally managed with early detection in infancy.</p>\n<p>Option D: <strong>Congenital deafness</strong> is included in RBSK due to the critical need for early intervention to facilitate normal speech and cognitive development. Early detection and intervention can greatly improve outcomes for affected children.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG5786",
      "difficulty": "medium"
    },
    {
      "text": "An epidemiologist gives a lecture on pandemics. He gives influenza pandemics as an example of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Seasonal trend"
        },
        {
          "id": 2,
          "text": "Secular trend"
        },
        {
          "id": 3,
          "text": "Point-source epidemic"
        },
        {
          "id": 4,
          "text": "Cyclical trend"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Influenza pandemics</strong> are an example of a <strong>cyclical trend</strong>.</p>\n<p>A cyclical trend is a type of<strong> periodic fluctuation</strong>. It occurs in <strong>cycles</strong> that are spread over short periods of time. This can be days, weeks, months, or even years.  Examples of the cyclic trend include influenza and <strong>rubella</strong>. Some <strong>non-infectious conditions</strong> can also display cyclical trends. An example of this is road traffic accidents occurring more frequently on the weekends. Knowledge of the cyclical pattern of diseases can be used to defend communities against the same.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Seasonal trend</strong> is another type of period fluctuation which refers to<strong> seasonal variation</strong> of diseases. Examples of diseases that follow this trend include <strong>measles</strong>, <strong>malaria</strong>, and upper respiratory tract infections. It can be related to <strong>environmental conditions</strong> such as temperature and humidity. Some non-infectious conditions which follow this trend are <strong>sunstroke</strong>, hay fever, and snakebite. Some epidemiologists consider this a form of cyclic trend.</p>\n<p>Option B: <strong>Secular</strong> or <strong>long-term trend</strong> signifies the changes seen in the occurrence of a disease over a long period of time. It implies a <strong>consistent change</strong> in a particular direction such as a progressive increase or decrease. Examples of conditions that follow this pattern are <strong>coronary heart disease</strong> and <strong>lung cancer</strong> which have shown a consistent upward trend. A decline in the occurrence of diseases such as tuberculosis and diphtheria has been noted in developed countries. </p>\n<p>Option C: <strong>Point-source epidemic</strong> is a type of common-source epidemic. In this type of epidemic, there are <strong>no secondary waves</strong> and the epidemic curve rises and falls rapidly. There is a <strong>clustering</strong> of <strong>cases</strong> within a narrow interval of time. All the cases develop within <strong>one incubation period</strong> of the specific disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4346",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about the steps of acute flaccid paralysis (AFP) surveillance?",
      "choices": [
        {
          "id": 1,
          "text": "Fecal samples should arrive at the lab within 48 hours of collection"
        },
        {
          "id": 2,
          "text": "All children with AFP should be tested within 72 hours of onset"
        },
        {
          "id": 3,
          "text": "Should be able to detect atleast 1 case of AFP/100000 children under 15 years"
        },
        {
          "id": 4,
          "text": "Fecal specimens should be transported at 2°C"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The statement \"<strong>Detect at least 1 case of AFP/100000 children under 15 years</strong>\" is <strong>true</strong> with regard to the steps of AFP surveillance.</p>\n<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">There are four steps under AFP surveillance:</span></p>\n<ol>\n<li> <strong>Finding and reporting </strong>children with AFP: </li>\n</ol>\n<ol class=\"listtype-number listindent1 list-number1\" start=\"1\">\n<ul class=\"listtype-bullet listindent2 list-bullet2\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The staff in all health facilities should </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>report </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>every case of AFP </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">in any </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>child less than 15 years of age.</strong></span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The surveillance system of the country should be able to detect at least </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>one case of AFP for every 1,00,000 children under 15 years of age</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, even in the absence of polio.</span></li>\n</ul>\n</ol>\n<ol class=\"listtype-number listindent1 list-number1\" start=\"2\" data-original-start=\"2\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Transporting </strong>stool samples for analysis:</span></li>\n<ul class=\"listtype-bullet listindent2 list-bullet2\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">All <strong>children with AFP</strong> should be reported and tested for </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>wild poliovirus </strong>within <strong>48 hours</strong> of onset. (option B)</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>faecal samples </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">are used to test for polio. </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The specimens should be collected </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>within the first two weeks after the onset </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">of paralysis since the highest concentration of the poliovirus is found during this period.</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Stool specimens have to be sealed in containers and stored immediately inside a refrigerator or packed between frozen ice packs at <strong>4–8 degrees Celsius</strong> in a cold box (option D). <strong>Specimens</strong> should arrive at the laboratory <strong>within 72 hours</strong> of collection (option A). Otherwise, they must be frozen at <strong>–20 degrees Celsius</strong> and then shipped frozen. The procedure is known as the <strong>“reverse cold chain”.</strong></span></li>\n</ul>\n</ol>\n<ol class=\"listtype-number listindent1 list-number1\" start=\"3\" data-original-start=\"3\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Isolating poliovirus:</strong></span></li>\n<ul class=\"listtype-bullet listindent2 list-bullet2\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Isolation of the virus followed by distinguishing between wild and vaccine-related poliovirus.</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">If the wild type is isolated, then the virologists identify which of the two surviving types is involved.</span></li>\n</ul>\n</ol>\n<ol class=\"listtype-number listindent1 list-number1\" start=\"4\" data-original-start=\"4\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Mapping the virus:</strong></span></li>\n<ul class=\"listtype-bullet listindent2 list-bullet2\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">If the wild type of virus is found, the genetic makeup of the virus is further studied and is compared with the reference bank of known polioviruses to know about the </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>geographical origin of the virus.</strong></span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Once the geographical area is identified, the source of the importation virus can be known. </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Immunization strategies </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">can be determined accordingly.</span> </li>\n</ul>\n</ol>\n<p>The <strong>differential diagnosis</strong> for <strong>acute flaccid paralysis</strong> includes:</p>\n<ul>\n<li>Non-polio enteroviruses</li>\n<li>West Nile virus</li>\n<li>Guillan–Barre syndrome</li>\n<li>Other neurotropic viruses: rabies, varicella-zoster, and Japanese encephalitis. </li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2054",
      "difficulty": "hard"
    },
    {
      "text": "A patient comes with a dirty and lacerated wound. He had received a full course of tetanus vaccination previously and his last dose was about 4 years ago. Which of the following does he require?",
      "choices": [
        {
          "id": 1,
          "text": "Full course of tetanus vaccination"
        },
        {
          "id": 2,
          "text": "No vaccination needed"
        },
        {
          "id": 3,
          "text": "Tetanus toxoid + immunoglobulin"
        },
        {
          "id": 4,
          "text": "Single shot of tetanus toxoid vaccine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A patient with a dirty and lacerated wound who completed a <strong>full course</strong> of tetanus vaccination <strong>4 years back</strong> comes under <strong>category A</strong>.</p>\n<p>As the patient has <strong>completed</strong> his <strong>full course</strong> of tetanus vaccination and the previous shot was<strong> within 5 years</strong>, <strong>no additional action</strong> is needed. Only <strong>wound care</strong> has to be done.</p><hr><h3>Related Pearl: Post exposure prophylaxis  for tetanus</h3><p>Prophylaxis is given based on patient category:</p>\n<p>A. Full immunization or a booster dose within the past 5 years.</p>\n<p>B. Full immunization or a booster dose &gt; 5 years ago but &lt; 10 years.</p>\n<p>C. Full immunization or a booster dose &gt; 10 years ago.</p>\n<p>D. Unknown or never taken immunization</p>\n<table>\n<tbody>\n<tr>\n<td>Category</td>\n<td>Clean wound</td>\n<td>Unclean wound</td>\n</tr>\n<tr>\n<td>A</td>\n<td>Only wound care</td>\n<td>Only wound care</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Wound care + TT single dose</td>\n<td>Wound care + TT single dose</td>\n</tr>\n<tr>\n<td>C</td>\n<td>Wound care + TT single dose</td>\n<td>Wound care + TT single dose + Human tetanus immunoglobulin&nbsp;</td>\n</tr>\n<tr>\n<td>D</td>\n<td>Wound care + TT complete course</td>\n<td>Wound care + TT complete course + Human tetanus immunoglobulin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3459",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following statements is correct regarding the beneficiaries of the scheme that has the logo shown below?",
      "choices": [
        {
          "id": 1,
          "text": "It covers secondary and tertiary care hospitalization."
        },
        {
          "id": 2,
          "text": "It provides health insurance of upto 1,00,000 Rs. per family per year."
        },
        {
          "id": 3,
          "text": "Service is provided to families with a maximum of 5 members."
        },
        {
          "id": 4,
          "text": "The insurance is provided in the form of cash to the families."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows the logo of the <strong>Ayushman Bharat scheme</strong>.<strong> </strong>The correct statement is Option A - <strong>It covers secondary and tertiary care hospitalization.</strong></p>\n<p>Ayushman Bharat-National Health Protection Mission (<strong>AB-NHPM</strong>) aims to build a comprehensive need-based health care service and targets to build a '<strong>New</strong> <strong>India 2022'</strong>. Its components are:</p>\n<ul>\n<li>The first component is the creation of 1,50,000 <strong>Health &amp; Wellness Centres</strong> (HWCs) to deliver comprehensive primary health care (CPHC), covering both maternal and child health services and non-communicable diseases, including free essential drugs and diagnostic services.</li>\n<li>The second component is the <strong>Pradhan Mantri Jan Arogya Yojana</strong> (PM-JAY), which provides health insurance cover of Rs. 5 lakhs per year to over 10 crore poor and vulnerable families for seeking secondary and tertiary care.</li>\n</ul>\n<p>Benefits under the scheme:</p>\n<ul>\n<li>The government provides health<strong> insurance</strong> <strong>coverage</strong> of up to <strong>Rs. 5,00,000</strong> per <strong>family per year</strong>(Option B).</li>\n<li>All families listed in the Socio-Economic Caste Census (SECC) database as per the defined criteria will be covered. <strong>No cap </strong>on<strong> family size </strong>and <strong>age of members </strong>(Option C).</li>\n<li>Priority is given to a girl child, women, and senior citizens.</li>\n<li><strong>Free treatment</strong> is available at<strong> all public </strong>and<strong> empaneled private hospitals </strong>in times of need.</li>\n<li>It covers <strong>secondary and tertiary care </strong>hospitalization.</li>\n<li>1,350 medical packages covering surgery, medical and daycare treatments, the cost of medicines, and diagnostics.</li>\n<li>All <strong>pre-existing diseases </strong>are <strong>covered. </strong>Hospitals <strong>cannot deny </strong>treatment.</li>\n<li><strong>Cashless</strong> and <strong>paperless</strong> access to quality health care services (Option D).</li>\n<li>Hospitals will not be allowed to charge any additional money from beneficiaries for the treatment.</li>\n<li>A 24X7 helpline number is available for information, assistance, complaints, and grievances.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2c91218fbfc947b5b10d7bc5c40d6599x814x470.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a35c805d486404dba97c8ff60f2c680x720x386.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f919a48b34474f79a050da1dcda1164e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6749",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following parameters is used for measuring the endemicity of malaria in a community?",
      "choices": [
        {
          "id": 1,
          "text": "Slide positivity rate"
        },
        {
          "id": 2,
          "text": "Spleen rate"
        },
        {
          "id": 3,
          "text": "Annual blood examination rate"
        },
        {
          "id": 4,
          "text": "Annual parasite incidence"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> spleen rate</strong> is used for measuring the <strong>endemicity</strong> of malaria in a <strong>community</strong>.</p>\n<p>The spleen rate refers to the percentage of children <strong>aged 2 to 10 years</strong> showing an <strong>enlarged spleen</strong>. Surveys focusing on spleen enlargement exclude adults since various factors other than malaria can cause splenic enlargement in this population. The spleen rate is a commonly employed measure measuring the <strong>endemicity</strong> of malaria in a <strong>community.</strong></p>\n<p>The <strong>slide positivity rate</strong> represents the proportion of <strong>slides</strong> that <strong>test positive</strong> for the presence of malarial parasites, regardless of the specific species. It provides information on the <strong>trend</strong> of <strong>malaria transmission</strong>.</p>\n<div class=\"page\" title=\"Page 294\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The <strong>annual blood examination rate</strong> is the percentage of the <strong>number of slides</strong> examined in a population. It is an index of <strong>operational efficiency</strong>.</p>\n<p>The <strong>annual parasitic incidence</strong> (API) is a method of assessing the <strong>incidence</strong> of malaria within a community. It involves comprehensive active and passive surveillance, with confirmed cases determined through blood examinations. In India, regions with an <strong>API≥2 per 1000 population</strong> per year are categorized as <strong>high-risk</strong> areas, making them eligible for targeted vector control measures.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Malarial parameters</h3><p>Malarial parameters:</p>\n<table>\n<tbody>\n<tr>\n<td>Parameter</td>\n<td>Formula</td>\n</tr>\n<tr>\n<td>Annual Parasite Incidence</td>\n<td>\n<p>Confirmed cases in one year</p>\n<p>-----------------------------------&times;1000<br />Population under surveillance</p>\n</td>\n</tr>\n<tr>\n<td>Annual Blood Examination Rate</td>\n<td>\n<p>Number of slides examined</p>\n<p>-----------------------------------&times;100 <br />&nbsp; &nbsp; &nbsp; Population</p>\n</td>\n</tr>\n<tr>\n<td>Slide positivity Rate</td>\n<td>Percentage of slides found positive irrespective of species</td>\n</tr>\n<tr>\n<td>Slide Falciparum Rate</td>\n<td>Percentage of slides positive for <em>P. falciparum</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9605",
      "difficulty": "hard"
    },
    {
      "text": "You are a supervising officer doing a quality check of vaccine storage at a PHC. You need not perform a shake test on which of the following vaccines?<div class='question-desc-html'><ol>\n<li>MMR vaccine</li>\n<li>DPT vaccine</li>\n<li>Hepatitis B vaccine</li>\n<li>OPV</li>\n<li>Rabies vaccine</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 4, and 5"
        },
        {
          "id": 2,
          "text": "2 and 3"
        },
        {
          "id": 3,
          "text": "1, 2, and 4"
        },
        {
          "id": 4,
          "text": "3 and 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>MMR </strong>(Measles, mumps, rubella), <strong>OPV</strong> (Oral poliovirus vaccine), and <strong>rabies</strong> vaccines are <strong>not damaged by freezing</strong>. Hence <strong>shake test</strong> is <strong>not required</strong> for these vaccines.</p>\n<div class=\"page\" title=\"Page 129\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The <strong>shake test</strong> is used to check if the <strong>freeze-sensitive vaccines</strong> have been <strong>damaged</strong> by exposure to <strong>temperatures below 0°C</strong>. Once it has been <strong>thawed</strong>, the vial of <strong>freeze-damage vaccine</strong> no longer has the appearance of a cloudy liquid but tends to form flakes that <strong>settle down</strong> at the bottom of the vial.</p>\n</div>\n</div>\n</div>\n<p>Steps to perform the shake test:</p>\n<ul>\n<li>A <strong>frozen vaccine</strong> is used as a <strong>control vial</strong>, and the vial suspected to be damaged by freezing is taken as the test vial.</li>\n<li>Both are <strong>shaken after thawing</strong>,<strong> </strong>and the rate of <strong>sedimentation</strong> is <strong>compared</strong>.</li>\n<li>If the rate of <strong>sedimentation</strong> in the test vial is <strong>slower than</strong> that in the <strong>control</strong> vial, then it is <strong>usable</strong> and has not been damaged.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8e1d7fcab7b4460aa9557ded706a8a0dx600x796.JPEG\" alt=\"Explanation Image\"><p>Some of the most widely used <strong>vaccines</strong> are<strong> freeze sensitive</strong>:</p>\n<ul>\n<li><strong>Hepatitis B</strong></li>\n<li>Pentavalent</li>\n<li><strong>IPV </strong>(Inactivated poliovirus)</li>\n<li><strong>DPT </strong></li>\n<li>TT</li>\n<li>PCV</li>\n</ul>\n<p>Vaccines like <strong>BCG</strong>, <strong>Japanese encephalitis</strong>(live and inactivated), <strong>MMR, OPV, Rabies,</strong> and <strong>Varicella-zoster virus</strong> vaccines do not lose their potency and efficacy on freezing. Hence, these vaccines can be used again once they liquefy.</p><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8778",
      "difficulty": "medium"
    },
    {
      "text": "Match the following study designs with their respective units of study.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Study Designs</strong></td>\n<td><strong>Unit of study</strong></td>\n</tr>\n<tr>\n<td>1. Cohort Study</td>\n<td> a. Healthy people</td>\n</tr>\n<tr>\n<td>2. Ecological Study</td>\n<td> b. Individual</td>\n</tr>\n<tr>\n<td>3. Randomized control trial</td>\n<td> c. Population</td>\n</tr>\n<tr>\n<td>4. Field trial</td>\n<td> d. Patients</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-b, 2-c, 3-d, 4-a"
        },
        {
          "id": 2,
          "text": "1-b, 2-c, 3-a, 4-d"
        },
        {
          "id": 3,
          "text": "1-a, 2-c, 3-b, 4-d"
        },
        {
          "id": 4,
          "text": "1-a, 2-b, 3-d, 4-c"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct match is <strong>1-b, 2-c, 3-d, 4-a.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Study Designs</strong></td>\n<td><strong>Unit of study</strong></td>\n</tr>\n<tr>\n<td>1. Cohort Study</td>\n<td>b. Individual</td>\n</tr>\n<tr>\n<td>2. Ecological Study</td>\n<td>c. Population</td>\n</tr>\n<tr>\n<td>3. Randomized control trial</td>\n<td>d. Patients</td>\n</tr>\n<tr>\n<td>4. Field trial</td>\n<td>a. Healthy people</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><p>A <strong>cohort study</strong> is an analytical study involving the follow-up of a cohort (a group of people) with risk factors to check if they develop an outcome or disease. It uses <strong>individuals </strong>(exposed and non-exposed) <strong>as a unit</strong> of study.</p>\n<p>An <strong>ecological study</strong> is a type of analytical study that analyzes the health status and its relation with other variables. It is also called a <strong>correlational study</strong>, and it uses the <strong>population</strong> as a <strong>unit of study.</strong></p>\n<p>A <strong>randomized control trial</strong> is an experimental study in which an intervention is given to a group of patients participating in the study and compared to another group of patients with similar characteristics who are not given that intervention to be studied. It uses <strong>patients </strong>as the <strong>unit of study.</strong></p>\n<p><strong>Field tria</strong>l is an interventional type of study, done to evaluate preventional strategies. It is done on the ground/in the field with <strong>healthy people </strong>as the<strong> unit of study.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of epidemiological study</strong></td>\n<td><strong>Unit of study</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Analytical studies (hypothesis testing)</strong></p>\n</td>\n<td>   </td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cohort study/ Follow up study</li>\n</ul>\n</td>\n<td>Individual</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Case-control study</li>\n</ul>\n</td>\n<td>Individual</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cross-sectional study/ Prevalence study</li>\n</ul>\n</td>\n<td>Individual</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Ecological study/ Correlational study</li>\n</ul>\n</td>\n<td>Population</td>\n</tr>\n<tr>\n<td>\n<p><strong>Experimental studies (hypothesis confirmation)</strong></p>\n</td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Randomized control trial/ Clinical trials</li>\n</ul>\n</td>\n<td>Patients</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Field trial</li>\n</ul>\n</td>\n<td>Healthy people</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Community trial</li>\n</ul>\n</td>\n<td>Community</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of Epidemiological Study Designs</h3><p><strong>Types of Epidemiological Study Designs</strong></p>\n<p>The flow chart below gives a glance into the types of epidemiological study designs and where they are generally used.</p>\n<p><strong>Note:</strong>&nbsp;<strong>Descripitve study</strong> is used to <strong>formulate</strong> aetiological hypothesis of a disease. Whereas <strong>analytical study</strong> is used to <strong>test</strong> the hypothesis (i.e to accept or reject the hypothesis).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8bf47c838ad64276ab706c700cc1758cx1280x2995.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9699",
      "difficulty": "medium"
    },
    {
      "text": "Data obtained from an RCT testing a new hypolipidemic drug is given below. How many patients need to be treated to prevent one death? <div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td> </td>\n<td>Placebo group</td>\n<td>Hypolipidemic drug group</td>\n</tr>\n<tr>\n<td>Number of patients who died due to cardiovascular causes</td>\n<td>145</td>\n<td>20</td>\n</tr>\n<tr>\n<td>Total number of patients in each group</td>\n<td>1250</td>\n<td>1250</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "8"
        },
        {
          "id": 2,
          "text": "10"
        },
        {
          "id": 3,
          "text": "100"
        },
        {
          "id": 4,
          "text": "1000"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div><strong>10 patients </strong>need<span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> to be treated with the new hypolipidemic drug to prevent 1 death.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The<strong> number needed to treat </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\"><strong>(NNT) </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is defined as the number of individuals that need to be treated with the new drug to prevent 1 death </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(or </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">to save 1 life).</span></div>\n<div> </div>\n<div><span class=\"ace-all-bold-hthree\"><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>NNT = 1/ARR </strong></span></span><span class=\"ace-all-bold-hthree\"><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">or 100/ARR, if the absolute risk reduction is already in percentage.</span></span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Here, </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>ARR </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is the </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>absolute risk reduction</strong>. ARR is the <strong>difference in the incidence between the placebo and the drug group</strong>. This <strong>formula </strong>is the <strong>same</strong> <strong>as </strong>that for<strong> attributable risk</strong>. Note that in clinical epidemiology, <strong>absolute risk reduction/increase</strong> is used identically <strong>to attributable risk</strong>.</span></div>\n<div> </div>\n<div><strong><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Calculation:</span></strong></div>\n<div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><br />ARR = Incidence in the placebo group — Incidence in the drug group</span></div>\n</div>\n<div>ARR = 145/1250 <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> — 20/1250</span></div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">ARR = 125/1250 = 1/10</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">NNT = 1/ARR = 10</span></div>\n<div> </div>\n<div>Thus, 10 patients need to be treated with the new hypolipidemic drug to prevent one death due to cardiovascular causes. </div><hr><h3>Related Pearl: Relative and Attributable Risk</h3><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\" alt=\"Pearl Image\"><ul>\n<li>It is the direct measure of the <strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where, </li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td> </td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c96f4beb9eb942899198d757d3388918x1280x904.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9949",
      "difficulty": "medium"
    },
    {
      "text": "Under which of the following schemes does the government provide free cooking (LPG) connections to all families below the poverty line?",
      "choices": [
        {
          "id": 1,
          "text": "Ujjwala"
        },
        {
          "id": 2,
          "text": "Ujjawala"
        },
        {
          "id": 3,
          "text": "UJALA"
        },
        {
          "id": 4,
          "text": "LAQSHYA"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>Ujjwala Yojana</strong> (<strong>note spelling without \"a\"</strong>) is for providing 5 crore free cooking (LPG) connections to all families below the poverty line till 2019.</p>\n<p>The <strong>Ujjawala Scheme</strong> is for the prevention of trafficking and for the rescue, rehabilitation, and reintegration of victims of trafficking for commercial sexual exploitation.</p>\n<p><strong>UJALA</strong> (Unnat Jyoti by <strong>Affordable LEDs</strong> for All) scheme was established by replacing the Bachat Lamp Yojana. According to this scheme, <strong>LED bulbs</strong> would be distributed by the electricity distribution company at subsidized rates to every grid-connected customer with a metered connection.</p>\n<p>The <strong>LAQSHYA initiative</strong> is for improving the <strong>quality </strong>of <strong>labor rooms</strong> and providing respectful maternity care. It also includes expanding the obstetric ICUs at government medical college hospitals.</p>\n<p><strong>Logo of the Ujjwala Yojana:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b9679c8fe5254640bb3615f0773b43f5x600x450.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8581",
      "difficulty": "easy"
    },
    {
      "text": "As a medical officer, you have to calculate the secondary attack rate of an unknown respiratory infection in your village. Considering the incubation period of the disease to be one week, which of the following would you include in the denominator?",
      "choices": [
        {
          "id": 1,
          "text": "Total number of close contacts both immunized and non-immunized"
        },
        {
          "id": 2,
          "text": "Total number of susceptible people along with the primary case"
        },
        {
          "id": 3,
          "text": "Total number of susceptible close contacts"
        },
        {
          "id": 4,
          "text": "Total number of close contacts developing the disease within 1 week"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Total number of susceptible close contacts</strong> is a part of the denominator of the secondary attack rate.</p>\n<p>The<strong> secondary attack rate</strong> is defined as the <strong>probability</strong> that <strong>disease occurs</strong> among susceptible persons, following<strong> exposure</strong> to an <strong>infectious person</strong> within the range of the <strong>incubation period</strong>.</p>\n<p><strong>Secondary attack rate (SAR)</strong> = (Number of exposed or susceptible persons developing the disease within the incubation period x 100)/ (Total number of susceptible close contacts).</p>\n<p>The secondary attack rate measures the <strong>communicability</strong> of the disease. The ones who are dead/ <strong>immunized</strong>/ not susceptible/ <strong>primary cases</strong> are <strong>excluded from the denominator</strong>.</p><hr><h3>Related Pearl: Morbidity Measurements in Epidemiology</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5e17c2ec999e4412beacae58dadc5ea4x1280x1933.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7026",
      "difficulty": "medium"
    },
    {
      "text": "Under the program whose logo is given below, district hospitals are considered ____________",
      "choices": [
        {
          "id": 1,
          "text": "Primary level"
        },
        {
          "id": 2,
          "text": "Secondary level"
        },
        {
          "id": 3,
          "text": "Tertiary level "
        },
        {
          "id": 4,
          "text": "Intermediate level"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Under the <strong>National Programme for the Control of Blindness and Visual Impairment (NPCBVI)</strong>, whose logo is shown above, <strong>district hospitals</strong> are considered <strong>secondary</strong> level.</p>\n<p>The levels of eye care, according to NPCBVI are:</p>\n<ul>\n<li>Primary level: Sub-district level hospitals, community health centers, mobile ophthalmic units, upgraded PHCs, link workers, and Panchayats.</li>\n<li>Secondary level: <strong>District hospitals</strong>, NGO eye hospitals</li>\n<li>Tertiary levels: Regional institutes of Ophthalmology, medical colleges.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/535327a629b74f60a3d6c1688fdee1e1x378x378.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/458184170487477698e883ebd847fd81.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7468",
      "difficulty": "medium"
    },
    {
      "text": "All the following indices are useful for the measurement of disability except?<div class='question-desc-html'><p>PQLI - Physical Quality of Life Index<br />DALY - Disability Adjusted Life Years</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Sullivan's index"
        },
        {
          "id": 2,
          "text": "Active Life Expectancy"
        },
        {
          "id": 3,
          "text": "PQLI"
        },
        {
          "id": 4,
          "text": "DALY"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>PQLI</strong> includes infant <strong>mortality rate, literacy, </strong>and<strong> life expectancy at 1 year</strong> whereas other indicators are directly related to the measurement of disability.</p>\n<p>Disability rates include the following:</p>\n<p><strong>Sullivan's index</strong> is also known as <strong>disability-free life expectancy (DFLE) or active life expectancy</strong>. It is the average <strong>number of years</strong> an individual is expected to <strong>live free of disability</strong> if the current patterns of mortality and disability continue to apply. It doesn’t take into account premature death. (Option A and B)<br />Disability-free life expectancy = (Life expectancy) - (the duration of the disability).</p>\n<p><strong>DALY</strong> is the best measure of the overall disease burden in a defined population and the effectiveness of interventions. It can measure both mortality and disability together. (Option D)<br />DALY = Years of lost life (<strong>YLL</strong>) + Years lost of disability (<strong>YLD</strong>)</p>\n<p><strong>HALE</strong> (Health Adjusted Life Expectancy) is an indicator that can be used to estimate the number of <strong>years</strong> a newborn is expected to live <strong>in full health</strong> based on the <strong>current rates</strong> of<strong> ill health</strong> and <strong>mortality</strong>. HALE is calculated using the <strong>life expectancy </strong>at<strong> birth</strong> with an <strong>adjustment </strong>for time spent in<strong> poor health</strong>. It captures both fatal and non-fatal health outcomes of average levels of population health. It is also <strong>sensitive</strong> to <strong>changes over time</strong> or differences between countries in the <strong>distribution of health states</strong>.</p>\n<p><strong>QALY </strong>(Quality-adjusted life years) is used to assess <strong>disease burden</strong> by considering both the quality and length of life. It helps evaluate the cost-effectiveness of medical treatments, based on the number of additional years of life the intervention can provide, adjusted for quality.</p><hr><h3>Related Pearl: HDI vs. PQLI</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Human Development Index&nbsp;</strong><strong>(HDI)</strong></p>\n</td>\n<td><strong>Physical Quality of Life Index (PQLI)</strong></td>\n</tr>\n<tr>\n<td><strong>Components</strong></td>\n<td>\n<p>Longevity (Life expectancy at birth)</p>\n<p>A decent standard of living (Real GNI per capita in PPP US$)</p>\n<p>Knowledge (mean years of schooling and expected years of schooling)</p>\n</td>\n<td>\n<p>Life expectancy at 1 year of age&nbsp;</p>\n<p>Infant Mortality rate</p>\n<p>Literacy rate</p>\n</td>\n</tr>\n<tr>\n<td><strong>Range</strong></td>\n<td>0 to +1</td>\n<td>0 to 100</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: QALY vs. DALY</h3><p>QALY and DALY are disability indicators used as measures of health in a population.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>QALY </strong>(Quality Adjusted Life Years)</p>\n</td>\n<td>\n<p><strong>DALY&nbsp;</strong>(Disability Adjusted Life Years)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Measures <strong>quality of life</strong> in health gain</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Measures <strong>health loss</strong> in quality of life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Indicator of <strong>cost-effectiveness</strong> of intervention</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Indicator of overall <strong>burden of disease</strong> in a population</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Expressed as 1 or 0 where,</p>\n<p>1 = Perfect health</p>\n<p>0 = Death</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Expressed as 0 or 1 where,</p>\n<p>0 = Perfect health</p>\n<p>1 = Death</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3791",
      "difficulty": "medium"
    },
    {
      "text": "A PSM intern surveying a rural hostel notices multiple rat infestations on the premises. Anticipating ill health effects, he calculated the cheopsis index and found it to be more than 1. What is the inference gained from his observation?",
      "choices": [
        {
          "id": 1,
          "text": "There is a high prevalence of plague among the inhabitants"
        },
        {
          "id": 2,
          "text": "There is a high likelihood of plague outbreak"
        },
        {
          "id": 3,
          "text": "It indicates a high prevalence of diseased rats"
        },
        {
          "id": 4,
          "text": "It indicates a low potential of disease spread from the rodent"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Cheopis index among the flea indices indicates that there is a <strong>high likelihood of an outbreak.</strong></p>\n<p>It is the <strong>best determinant</strong> of potential plague outbreaks.It is the measure of the <strong>average number</strong> of <em>Xenopsylla cheopis</em><strong> </strong>per rat.  If this <strong>index is &gt; 1</strong>, it indicates that there is a<strong> high likelihood of a plague outbreak</strong>. </p>\n<p>A plague is a zoonotic infection caused by <em><strong>Yersinia pestis</strong></em> and is usually transmitted by the bite of an i<strong>nfected rat flea</strong>. Rodent burrows serve as a favorable surface for the bacteria to grow and thus get transmitted by rat fleas. The most common vector that effectively spreads the infection is <strong>Xenopsylla cheopis</strong>. <strong>Flea indices</strong> are used to assess the <strong>density of the vector</strong>. </p><hr><h3>Related Pearl: Flea Indices</h3><p>They are useful in measurements of density of fleas.</p>\n<p>They include:&nbsp;</p>\n<ul>\n<li><strong>Total flea index</strong> &ndash; it is the average number of fleas of all species per rat</li>\n<li><strong>Cheopis index</strong> - it is the average number of <em>Xenopsylla cheopis</em> species per rat,hence it is a <strong>specific flea index</strong>. It indicates the <strong>maximum explosiveness</strong> of the situation</li>\n</ul>\n<ul>\n<li><strong>Specific percentage of fleas</strong> &ndash; it is a precentage of different species of fleas that are found on rats.</li>\n<li><strong>Burrow index</strong> &ndash; It is the average&nbsp; number of free living flea per species per rodent burrow.</li>\n</ul><hr><h3>Related Pearl: Rat Fleas</h3><ul>\n<li>Rat fleas (<em>Xenopsylla cheopis</em>) belong to the genus <strong>Xenopsylla.</strong></li>\n<li>Their morphology includes <strong>a conical head</strong>, absent neck, a thorax with 3 segments, and an abdomen with 10 segments. They have <strong>three pairs of legs</strong> and no wings.</li>\n<li>The <strong>four stages</strong> in their life cycle are egg, larva, pupa, and adult.</li>\n<li>They cannot fly but can <strong>leap</strong> up to <strong>6 inches horizontally</strong>.</li>\n<li>They transmit diseases by<strong> biting</strong>, mechanical transmission, and <strong>feces.</strong></li>\n<li><strong>Flea indices</strong> that are used in flea surveys are the&nbsp;<strong>general flea index, specific flea index, percentage incidence of flea species,&nbsp;</strong>and <strong>rodent infestation rate.</strong></li>\n<li>Rat fleas are vectors for <strong>endemic typhus</strong> (murine typhus), <strong>chiggerosis</strong>, <strong>bubonic plague,</strong> and <strong>Hymenolepis diminuta</strong>.</li>\n<li>Insecticidal control is mainly by&nbsp;<strong>10% DDT.</strong></li>\n<li>Resistance to DDT, gamma-HCH, and dieldrin has been recorded.</li>\n<li>Repellants like <strong>diethyltoluamide</strong> and <strong>benzyl benzoate </strong>are efficient.</li>\n<li>Rodent control also aims to reduce flea infestation.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c23f2bce0b4c483d9cd264b0bd9c3cc4x1024x940.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG5754",
      "difficulty": "medium"
    },
    {
      "text": "The incidence rate of lung cancer is 120/100,000 person-years for smokers and 10/100,000 person-years for nonsmokers. The prevalence of smoking is 20% in the community. If the prevalence of smoking in the community was decreased to 10%, the excess incidence rate of lung cancer that could be averted in that community would be?",
      "choices": [
        {
          "id": 1,
          "text": "50/100,000"
        },
        {
          "id": 2,
          "text": "11/100,000"
        },
        {
          "id": 3,
          "text": "22/100,000"
        },
        {
          "id": 4,
          "text": "60/100,000"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 55\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>If the prevalence of smoking was reduced to 10%, <strong>11/100,000</strong> excess cases of lung cancer due to smoking could be averted.</p>\n<p>We can calculate this by using the <strong>population attributable risk</strong> (PAR) = <strong>(attributable risk) x (prevalence of exposure in the population)</strong>.</p>\n<div class=\"page\" title=\"Page 55\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 55\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The relative risk is defined as the incidence rate among the exposed (I<sub>e</sub>) divided by the incidence rate among the nonexposed (I<sub>o</sub>). <br />In this case, (120/100,000)/(10/100,000) = 12.</p>\n<p>The attributable risk (AR) is defined as Ie − Io = (120/100,000) − (10/100,000) = 110/100,000. <br />The attributable risk percentage is equal to [(Ie − Io) / Ie] × 100 = (110/100,000)/(120/100,000) = 92%.</p>\n<p>If the prevalence of smoking in the population is 20%, then the PAR is calculated as follows:</p>\n</div>\n</div>\n</div>\n</div>\n<p>    AR × prevalence of exposure = 110/100,00 × 20/100 = 22/100,000.</p>\n<div class=\"page\" title=\"Page 55\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>If the prevalence of smoking is 10%, then</p>\n<p>    AR × prevalence of exposure = 110/100,000 × 10/100 = 11/100,000.</p>\n<p>Therefore, excess incidence rate of lung cancer that can be avoided is (22/100,000) - (11/100,000) = (11/100,000)</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Relative and Attributable Risk</h3><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\" alt=\"Pearl Image\"><ul>\n<li>It is the direct measure of the <strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where, </li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td> </td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c96f4beb9eb942899198d757d3388918x1280x904.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3800",
      "difficulty": "hard"
    },
    {
      "text": "You are an intern in the paediatrics outpatient department. An overweight child, suspected of obesity is brought for assessment of body fat. The consultant on duty asks you to measure the skinfold thickness of the child. Which of the following regions are not commonly measured for skinfold thickness?",
      "choices": [
        {
          "id": 1,
          "text": "Mid-triceps"
        },
        {
          "id": 2,
          "text": "Mid-thigh"
        },
        {
          "id": 3,
          "text": "Subscapular"
        },
        {
          "id": 4,
          "text": "Suprailiac"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> mid-thigh region</strong> is not commonly measured for skinfold thickness.</p>\n<p>The assessment of skinfold thickness measures the amount of subcutaneous fat. Measurement of skinfold thickness is done as it is easily accessible. It is a rapid and non-invasive method for assessing body fat. The callipers used for this purpose are called <strong>Harpenden skin callipers</strong>. </p>\n<p>Measurements are taken from the following <strong>four</strong> sites :</p>\n<ol>\n<li><strong>Mid-triceps</strong> region</li>\n<li>Biceps region</li>\n<li><strong>Subscapular</strong> region</li>\n<li><strong>Suprailiac</strong> region</li>\n</ol>\n<p>The sum of the measurements should be less than 40 mm in boys and 50 mm in girls. </p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Disadvantages- Standards for subcutaneous fat do not exist for comparison. In extreme obesity, measurements cannot be taken. It has <strong>poor</strong> <strong>repeatability</strong>.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Indicators for Body fat</h3><p><strong>The indicators for body fat are:</strong></p>\n<p><strong>Body weight</strong>: +3SD (standard deviations) from the median weight for height as a cut-off point for obesity. For adults, some people calculate various other indicators such as:</p>\n<ul>\n<li><strong>Body mass index (Quetelet's index)</strong>: Weight (kg) / Square of height in metres</li>\n<li><strong>Ponderal index</strong>: Weight (kg)/Height^3 (m)</li>\n<li>Corpulence index: Actual weight /desirable weight.(Should not exceed 1.2)</li>\n</ul>\n<p><strong>Broca's index</strong> = Height (cm) - 100 . </p>\n<p><strong>Lorentz's formula</strong> <br />Ht (cm) - 100 - [ (Ht (cm) - 150) / 2 for women or 4 for men ]</p>\n<p><strong>Skinfold thickness:</strong> Four sites mid-triceps, biceps, subscapular and suprailiac regions. The sum of the measurements should be less than 40 mm in boys and 50 mm in girls.</p>\n<p><strong>Waist circumference and waist-hip ratio</strong>: At the mid point between the lower border of the rib cage and the iliac crest. There is an increased risk of metabolic complications for men with a waist circumference~ 102 cm, and women with a waist circumference~ 88 cm. A high WHR (&gt; 1.0 in men and&gt; 0.85 in women) indicates abdominal fat accumulation.</p>\n<p><strong>Total body water</strong></p>\n<p><strong>Total body potassium</strong></p>\n<p><strong>Body density </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0043",
      "difficulty": "medium"
    },
    {
      "text": "At a health camp, you notice a child with a fever and rash. On history taking, you find that her friend had similar symptoms 1 week back. How will you epidemiologically categorize the friend of the child you examined?",
      "choices": [
        {
          "id": 1,
          "text": "Index case"
        },
        {
          "id": 2,
          "text": "Primary case"
        },
        {
          "id": 3,
          "text": "Secondary case"
        },
        {
          "id": 4,
          "text": "Tertiary case"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given scenario, the friend of the child is categorized as the<strong> primary case</strong>. It is the <strong>first</strong> case of a communicable disease <strong>introduced</strong> into a <strong>population</strong> unit. </p>\n<p>An <strong>index case</strong> is the <strong>first </strong>case that comes to the <strong>notice</strong> of an <strong>investigator</strong> or physician.</p>\n<p>A<strong> secondary case</strong> is one that develops after <strong>contact</strong> with the <strong>primary case</strong>. </p>\n<p>A <strong>suspect case</strong> refers to a patient with all the disease's features but has <strong>not</strong> been <strong>diagnosed</strong> with it <strong>yet</strong>.</p>\n<p>Note: There is no such term as tertiary case.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7704",
      "difficulty": "medium"
    },
    {
      "text": "You are a physician at a primary health center. A 2-year-old child weighing 12 kg is brought to you. He appears lethargic and is not taking food or fluids orally. On examination, he has a respiratory rate of 45/min, and stridor is heard. What is the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Give a dose of IV chloramphenicol and urgently refer to the hospital"
        },
        {
          "id": 2,
          "text": "Give oral amoxicillin for 5 days"
        },
        {
          "id": 3,
          "text": "Administer IV antibiotics and ask the patient to be brought after 24 hours"
        },
        {
          "id": 4,
          "text": "Start antipyretics urgently"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The child in this case has features of<strong> severe pneumonia</strong> with the presence of <strong>danger signs</strong> like lethargy, inability to drink, and stridor. Therefore,<strong> pre-referral treatment </strong>like the first dose of injectable chloramphenicol should be given and <strong>urgently referred</strong> to a<strong> hospital.</strong> If chloramphenicol is not available, oral amoxicillin can be given.</p>\n<p>This is based on the <strong>revised WHO classification and treatment of childhood pneumonia at health facilities</strong>. Pneumonia with general danger signs like inability to drink, persistent vomiting, convulsions, lethargy or unconscious, stridor in a calm child, or severe malnutrition needs antibiotics with urgent referral to a higher center.</p>\n<p>The following image shows the IMNCI Guidelines for the treatment of pneumonia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a3c9238185584cfa92c170b85f89d42bx1280x1813.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3473",
      "difficulty": "easy"
    },
    {
      "text": "During rural postings at a CHC, you noticed a relative rise in dengue cases recently and would like to take measures to control the mosquitoes. Which among the following is not an anti-adult measure?",
      "choices": [
        {
          "id": 1,
          "text": "DDT "
        },
        {
          "id": 2,
          "text": "Malathion"
        },
        {
          "id": 3,
          "text": "Pyrethrum"
        },
        {
          "id": 4,
          "text": "Chlorpyrifos"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Chlorpyrifos</strong> is <strong>not </strong>an<strong> anti-adult </strong>measure in controlling mosquitoes.</p>\n<p><strong>DDT</strong>, <strong>malathion</strong>, and <strong>pyrethrum</strong> are <span>anti-adul<strong>t</strong> measures, whereas chlorpyrifos is an <strong>anti-larval</strong></span>.</p><hr><h3>Related Pearl: Mosquito Control Measures</h3><ul>\n<li><strong>Anti-larval measures</strong>\n<ul>\n<li><strong>Environmental control</strong>\n<ul>\n<li>This is done by <strong>source reduction</strong> by <strong>eliminating breeding places</strong> through appropriate methods for the different species.</li>\n<li><strong>Intermittent irrigation</strong> is also a method of environmental control</li>\n</ul>\n</li>\n<li><strong>Chemical control</strong>\n<ul>\n<li><strong>Mineral oils</strong>: Oldest known larvicidal method. Oils that are used are diesel oil, kerosene, crude oil fractions. Disadvantage is that it kills fish.</li>\n<li><strong>Paris green</strong>: Copper acetoarsenite is an emerald green, micro-crystalline powder and is insoluble in water. It is a <strong>stomach poison</strong> to larvae. It is not harmful to man or animals. Very effective against Anopheles as they are surface feeders.</li>\n<li><strong>Synthetic insecticides</strong>: Organo-phosphorous compounds like fenthion, chlorpyrifos and abate are larvicidal. Abate is least toxic.</li>\n</ul>\n</li>\n<li><strong>Biological control</strong>\n<ul>\n<li>The fish species <strong>Gambusia affinis</strong> and <strong>Lebister reticulatus</strong> (Barbados millions) feed on mosquito larvae.</li>\n<li>These are used in conjunction with other methods.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Anti-adult measures</strong>\n<ul>\n<li><strong>Residual sprays</strong>\n<ul>\n<li>Adult mosquitoes can be controlled by spraying with residual insecticides like <strong>DDT, Malathion, propoxur</strong> and<strong> gamma-HCH (lindane)</strong></li>\n<li><strong>Resistance</strong> to <strong>DDT</strong> has been shown by mosquitoes</li>\n</ul>\n</li>\n<li><strong>Space sprays</strong>\n<ul>\n<li>Space sprays are those in which <strong>insecticides</strong> are <strong>sprayed</strong> into the atmosphere in the form of a <strong>mist or fog</strong>.</li>\n<li><strong>Pyrethrum</strong> is a <strong>contact</strong>, <strong>nerve poison</strong> and is the most common insecticide used as a space spray. Its active principle is pyrethrin.</li>\n<li><strong>Ultra-low volume</strong> space spraying (ULV) is done with <strong>Malathion and fenitrothion.</strong></li>\n</ul>\n</li>\n<li><strong>Genetic control</strong> by sterile male technique, cytoplasmic incompatibility, sex distortion, etc.</li>\n</ul>\n</li>\n<li><strong>Protection against bites</strong>\n<ul>\n<li>Usage of <strong>mosquito nets</strong>, building screens and <strong>repellants </strong>like diethyltoluamide (deet), indalone, dimethylphthalate, dimethyl carbate, etc.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7358",
      "difficulty": "medium"
    },
    {
      "text": "A physician uses the following instrument to measure temperature in one of his patients and he wants to disinfect it before using it on another patient. It can be best disinfected by _______",
      "choices": [
        {
          "id": 1,
          "text": "Cresol"
        },
        {
          "id": 2,
          "text": "Dettol"
        },
        {
          "id": 3,
          "text": "Savlon"
        },
        {
          "id": 4,
          "text": "Lysol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given instrument is a<strong> clinical thermometer</strong>, and it is best disinfected using<strong> Savlon.</strong></p>\n<p><strong>Savlon </strong>is a <strong>quaternary ammonia compound (QAC)</strong> that contains <strong>Cetavlon (cetrimide)</strong> and<strong> Hibitane (chlorhexidine). </strong>Plastic items can be disinfected by keeping them in normal strength Savlon for<strong> 20 minutes. Clinical thermometers </strong>can be disinfected in savlon in just<strong> under 3 minutes</strong>.</p>\n<p><strong>Other options: </strong></p>\n<p>Option A -<strong> Cresol</strong> is a coal-tar disinfectant that is best used in 5-10% strength for disinfection of feces and urine.</p>\n<p>Option B - <strong>Chloroxylenol (Dettol)</strong> is an antiseptic that is active against streptococci. A 5% solution is suitable for disinfection of instruments and plastic equipment, with minimum contact of <strong>15 minutes</strong> required for disinfection.</p>\n<p>Option D - <strong>Lysol</strong> is a \"saponified cresol\" where cresol is emulsified with soap. It contains 50- 60 percent cresol and is a powerful disinfectant. A 2 percent solution of Lysol may be used for the disinfection of feces.</p><hr><h3>Related Pearl: Methods of sterilisation</h3><table>\n<tbody>\n<tr>\n<td><strong>Method of disinfection or sterilisation</strong></td>\n<td><strong>Material</strong></td>\n</tr>\n<tr>\n<td>Red Heat</td>\n<td>Inoculating wire loop, tip of forceps</td>\n</tr>\n<tr>\n<td>Incineration</td>\n<td>Contaminated clothes, animal carcasses, plastics like polythene</td>\n</tr>\n<tr>\n<td>Hot air oven</td>\n<td>Glasswares, scalpels, forceps, cutting instruments, test tubes</td>\n</tr>\n<tr>\n<td>Inspissator</td>\n<td>Heat labile culture media containing egg, sugar or serum</td>\n</tr>\n<tr>\n<td>Autoclave</td>\n<td>Culture media, dressings, gloves, aprons, all instruments except sharps, suture materials except catgut</td>\n</tr>\n<tr>\n<td>Isopropyl alcohol</td>\n<td>Clinical thermometers, stethoscopes, probes</td>\n</tr>\n<tr>\n<td>Methyl alcohol</td>\n<td>Fungal spores</td>\n</tr>\n<tr>\n<td>\n<p>Beta propiolactone/</p>\n<p>formaldehyde</p>\n</td>\n<td>Fumigation of operating theatres, wards and labs</td>\n</tr>\n<tr>\n<td>2% gluteraldehyde</td>\n<td>Cystoscopes, bronchoscopes, fibre-optic endoscopes, plastic ETT, face masks</td>\n</tr>\n<tr>\n<td>Plasma sterilisation</td>\n<td>Arthroscopes, urethroscopes</td>\n</tr>\n<tr>\n<td>Ethylene oxide</td>\n<td>Heart lung machines, respirators, dental equipments, sutures, books, clothings</td>\n</tr>\n<tr>\n<td>Filtration (Seitz filters)</td>\n<td>Bacterial vaccines, intravenous solutions</td>\n</tr>\n<tr>\n<td>5% cresol, hot air oven</td>\n<td>Sharp instruments</td>\n</tr>\n<tr>\n<td>\n<p>Ionising radiation</p>\n<p>(Cold air sterilization)</p>\n</td>\n<td>Catgut, swabs, plastic, syringes, needles, gloves, catheters, grafts</td>\n</tr>\n<tr>\n<td>Chlorhexidine</td>\n<td>Disinfecting surgeon&rsquo;s hands prior to surgery</td>\n</tr>\n<tr>\n<td>Iodophor</td>\n<td>Disinfecting surgical site prior to surgery</td>\n</tr>\n<tr>\n<td>70% ethanol</td>\n<td>Disinfectant skin prior to venepuncture or immunisation</td>\n</tr>\n<tr>\n<td>Thiomersal</td>\n<td>Preservative in vaccine</td>\n</tr>\n<tr>\n<td>Silver sulfadiazine</td>\n<td>Cleanse burn wounds</td>\n</tr>\n<tr>\n<td>Hypochlorite</td>\n<td>Cleanup of blood spill from a patient with hepatitis B or C</td>\n</tr>\n<tr>\n<td>Hydrogen peroxide</td>\n<td>Cleanse wounds</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Methods of Sterilization and Disinfection</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Spectrum</td>\n<td>Uses</td>\n</tr>\n<tr>\n<td><strong>1. Heat</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Hot air oven</td>\n<td>All</td>\n<td>Glasswares, sterilizing powders, oils, swabs and dressings</td>\n</tr>\n<tr>\n<td>Autoclaving</td>\n<td>All</td>\n<td>Linen, surgical instruments, laboratory ware, media and pharmaceutical products</td>\n</tr>\n<tr>\n<td>Boiling</td>\n<td>Most pathogens, some spores</td>\n<td>Metal tools, rubber or plastic equipment, cloth&nbsp;</td>\n</tr>\n<tr>\n<td>Pasteurization</td>\n<td>Vegetative bacteria</td>\n<td>Beverages, plastic hospital equipment</td>\n</tr>\n<tr>\n<td><strong>2. Ethylene oxide gas</strong></td>\n<td>All</td>\n<td>Heat-sensitive equipment like heart-lung machines, artificial valves, fabrics, respirators, cardiac catheters, books</td>\n</tr>\n<tr>\n<td><strong>3. Radiation</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>UV</td>\n<td>All</td>\n<td>Limited value due to poor penetration, can be used for plastic syringes, catheters, and laboratory cabinets</td>\n</tr>\n<tr>\n<td>Ionising</td>\n<td>All</td>\n<td>Surgical supplies, food</td>\n</tr>\n<tr>\n<td><strong>4. Chemicals</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Vegetative bacteria, viruses some spores</td>\n<td>Skin disinfection, hand washing</td>\n</tr>\n<tr>\n<td>Hydrogen peroxide</td>\n<td>Viruses, vegetative bacteria, spores and fungi</td>\n<td>High-level disinfectant, antiseptic for wounds and discharging ulcers</td>\n</tr>\n<tr>\n<td>Chlorine</td>\n<td>Viruses, vegetative bacteria, fungi</td>\n<td>To disinfect water</td>\n</tr>\n<tr>\n<td>Iodophors</td>\n<td>Viruses, vegetative bacteria, fungi, lethal to spore-bearing organisms</td>\n<td>Skin disinfection, disinfect blood culture bottles and medical equipment</td>\n</tr>\n<tr>\n<td>Crude phenol</td>\n<td>Gram-positive and gram-negative bacteria, but only slowly effective against spores and acid-fast bacteria.</td>\n<td>Disinfection of faeces, mopping floors and cleaning drains.</td>\n</tr>\n<tr>\n<td><strong>5. Glutaraldehyde&nbsp;</strong></td>\n<td>&nbsp;All</td>\n<td>Endoscopes, bronchoscopes</td>\n</tr>\n<tr>\n<td>6. <strong>Quarternary ammonium compounds</strong></td>\n<td>Most bacteria, fungi, lipophilic viruses&nbsp;</td>\n<td>General cleaning</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/97bdcbaccd084a328d7f3970feb130f4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4323",
      "difficulty": "medium"
    },
    {
      "text": "What does the number 4 in the given diagram related to hypertension denote?",
      "choices": [
        {
          "id": 1,
          "text": "Undiagnosed hypertensive subjects"
        },
        {
          "id": 2,
          "text": "Diagnosed hypertensive subjects not on treatment"
        },
        {
          "id": 3,
          "text": "Normotensive individuals"
        },
        {
          "id": 4,
          "text": "Diagnosed but treated hypertensives"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above diagram depicts the <strong>rule of halves</strong>,<strong> </strong>which is observed in <strong>hypertension</strong>, and \"number 4\" denotes <strong>undiagnosed patients.</strong></p>\n<p>The rule of halves depicts that only about half of the hypertensive subjects in the general population of most developed countries were aware of the condition and only half of those aware are being treated and only half of those being treated are considered to be adequately treated. </p>\n<p>The numbers in the diagram denote the following:</p>\n<ol>\n<li>Whole community</li>\n<li>Normotensive subjects</li>\n<li>Hypertensive subjects</li>\n<li>Undiagnosed hypertension</li>\n<li>Diagnosed hypertension</li>\n<li>Diagnosed but untreated</li>\n<li>Diagnosed and treated</li>\n<li>Inadequately treated</li>\n<li>Adequately treated</li>\n</ol>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3be2b7531c914ea1ab8bb5641e0c3e55.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3166",
      "difficulty": "hard"
    }
  ]
}